Interactions	O
of	O
a	O
transcriptional	B-DNA
activator	I-DNA
in	O
the	O
env	B-DNA
gene	I-DNA
of	O
the	O
mouse	O
mammary	O
tumor	O
virus	O
with	O
activation-dependent	B-protein
,	I-protein
T	I-protein
cell-specific	I-protein
transacting	I-protein
factors	I-protein
.	O

The	O
mouse	O
mammary	O
tumor	O
virus	O
env	B-DNA
gene	I-DNA
contains	O
a	O
transcriptional	B-DNA
activator	I-DNA
(	O
META	B-DNA
)	O
that	O
can	O
control	O
transcription	O
of	O
the	O
adjacent	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
region	I-DNA
.	O

Transcriptional	O
control	O
by	O
META	B-DNA
parallels	O
that	O
of	O
several	O
lymphokine	B-DNA
genes	I-DNA
,	O
being	O
specific	O
to	O
T	B-cell_type
cells	I-cell_type
,	O
dependent	O
on	O
their	O
activation	O
,	O
and	O
inhibited	O
by	O
the	O
immunosuppressive	O
drug	O
cyclosporine	O
(	O
CsA	O
)	O
.	O

DNase	B-protein
I	I-protein
footprinting	O
indicated	O
that	O
nuclear	B-protein
factors	I-protein
from	O
activated	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
bound	O
a	O
promoter-proximal	B-DNA
site	I-DNA
,	O
META	B-DNA
(	I-DNA
P	I-DNA
)	I-DNA
,	O
and	O
a	O
promoter-distal	B-DNA
site	I-DNA
,	O
META	B-DNA
(	I-DNA
D+	I-DNA
)	I-DNA
,	O
within	O
the	O
400-base	B-DNA
pair	I-DNA
META	I-DNA
region	I-DNA
.	O

Nuclear	B-protein
factors	I-protein
from	O
unstimulated	O
,	O
but	O
not	O
from	O
activated	O
cells	O
,	O
bound	O
a	O
site	O
,	O
META	B-DNA
(	I-DNA
D-	I-DNA
)	I-DNA
,	O
adjacent	O
to	O
META	B-DNA
(	I-DNA
D+	I-DNA
)	I-DNA
.	O

META	B-DNA
(	I-DNA
D+	I-DNA
)	I-DNA
directed	O
transcription	O
of	O
a	O
linked	O
luciferase	B-DNA
gene	I-DNA
,	O
and	O
gel	O
shift	O
analysis	O
revealed	O
binding	O
of	O
inducible	O
,	O
CsA-sensitive	B-protein
T	I-protein
cell	I-protein
factors	I-protein
,	O
in	O
parallel	O
with	O
transfection	O
results	O
.	O

Authentic	O
NFAT	B-DNA
and	I-DNA
NF-kappaB	I-DNA
targets	I-DNA
did	O
not	O
compete	O
for	O
the	O
META	B-protein
(	I-protein
D+	I-protein
)	I-protein
binding	I-protein
factor	I-protein
(	O
s	O
)	O
.	O

The	O
SV40	B-DNA
core	I-DNA
sequence	I-DNA
competed	O
for	O
META	B-protein
(	I-protein
D+	I-protein
)	I-protein
binding	I-protein
factors	I-protein
,	O
but	O
META	B-DNA
(	I-DNA
D+	I-DNA
)	I-DNA
failed	O
to	O
compete	O
for	O
the	O
complexes	O
obtained	O
with	O
the	O
SV40	O
probe	O
.	O

Our	O
results	O
,	O
taken	O
together	O
,	O
indicate	O
that	O
META	B-DNA
(	I-DNA
D+	I-DNA
)	I-DNA
is	O
a	O
novel	O
transcriptional	B-DNA
enhancer	I-DNA
element	I-DNA
that	O
is	O
similar	O
in	O
its	O
cell-type	O
specificity	O
,	O
activation	O
dependence	O
,	O
and	O
CsA	O
sensitivity	O
to	O
the	O
NFAT	B-DNA
element	I-DNA
.	O

It	O
may	O
be	O
relevant	O
to	O
the	O
role	O
of	O
MMTV	O
in	O
expression	O
of	O
Mls	B-protein
antigens	I-protein
or	O
the	O
induction	O
of	O
T	O
cell	O
lymphomas	O
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

15	NULL
,	NULL
Issue	NULL
of	NULL
April	NULL
12	NULL
,	NULL
pp	NULL
.	NULL

8942-8950	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Interactions	NULL
of	NULL
a	NULL
Transcriptional	NULL
Activator	NULL
in	NULL
the	NULL
env	NULL
Gene	NULL
of	NULL
the	NULL
Mouse	NULL
Mammary	NULL
Tumor	NULL
Virus	NULL
with	NULL
Activation-dependent	NULL
,	NULL
T	NULL
Cell-specific	NULL
Transacting	NULL
Factors*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
19	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
January	NULL
22	NULL
,	NULL
1996	NULL
)	NULL
Damaraju	NULL
Sambasivarao	NULL
and	NULL
Verner	NULL
Pacetkaut	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Medical	NULL
Sciences	NULL
Building	NULL
,	NULL
University	NULL
of	NULL
Alberta	NULL
,	NULL
Edmonton	NULL
,	NULL
Alberta	NULL
T6G	NULL
2H7	NULL
,	NULL
Canada	NULL
The	NULL
mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
erv	NULL
gene	NULL
contains	NULL
a	NULL
transcriptional	NULL
activator	NULL
(	NULL
META	NULL
)	NULL
that	NULL
can	NULL
control	NULL
transcription	NULL
of	NULL
the	NULL
adjacent	NULL
long	NULL
terminal	NULL
repeat	NULL
region	NULL
.	NULL

Transcriptional	NULL
control	NULL
by	NULL
META	NULL
parallels	NULL
that	NULL
of	NULL
several	NULL
lymphokine	NULL
genes	NULL
,	NULL
being	NULL
specific	NULL
to	NULL
T	NULL
cells	NULL
,	NULL
dependent	NULL
on	NULL
their	NULL
activation	NULL
,	NULL
and	NULL
inhibited	NULL
by	NULL
the	NULL
immu-nosuppressive	NULL
drug	NULL
cyclosporine	NULL
(	NULL
CsA	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
indicated	NULL
that	NULL
nuclear	NULL
factors	NULL
from	NULL
activated	NULL
T	NULL
lymphocytes	NULL
bound	NULL
a	NULL
promoter-proximal	NULL
site	NULL
,	NULL
META	NULL
(	NULL
P	NULL
)	NULL
,	NULL
and	NULL
a	NULL
promoter-distal	NULL
site	NULL
,	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
,	NULL
within	NULL
the	NULL
400-base	NULL
pair	NULL
META	NULL
region	NULL
.	NULL

Nuclear	NULL
factors	NULL
from	NULL
unstimulated	NULL
,	NULL
but	NULL
not	NULL
from	NULL
activated	NULL
cells	NULL
,	NULL
bound	NULL
a	NULL
site	NULL
,	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
,	NULL
adjacent	NULL
to	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
.	NULL

META	NULL
(	NULL
D+	NULL
)	NULL
directed	NULL
transcription	NULL
of	NULL
a	NULL
linked	NULL
luciferase	NULL
gene	NULL
,	NULL
and	NULL
gel	NULL
shift	NULL
analysis	NULL
revealed	NULL
binding	NULL
of	NULL
inducible	NULL
,	NULL
CsA-sensitive	NULL
T	NULL
cell	NULL
factors	NULL
,	NULL
in	NULL
parallel	NULL
with	NULL
transfection	NULL
results	NULL
.	NULL

Authentic	NULL
NFAT	NULL
and	NULL
NF-	NULL
<	NULL
B	NULL
targets	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
.	NULL

The	NULL
SV40	NULL
core	NULL
sequence	NULL
competed	NULL
for	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
binding	NULL
factors	NULL
,	NULL
but	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
failed	NULL
to	NULL
compete	NULL
for	NULL
the	NULL
complexes	NULL
obtained	NULL
with	NULL
the	NULL
SV40	NULL
probe	NULL
.	NULL

Our	NULL
results	NULL
,	NULL
taken	NULL
together	NULL
,	NULL
indicate	NULL
that	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
is	NULL
a	NULL
novel	NULL
transcriptional	NULL
enhancer	NULL
element	NULL
that	NULL
is	NULL
similar	NULL
in	NULL
its	NULL
cell-type	NULL
specificity	NULL
,	NULL
activation	NULL
de-pendence	NULL
,	NULL
and	NULL
CsA	NULL
sensitivity	NULL
to	NULL
the	NULL
NFAT	NULL
element	NULL
.	NULL

It	NULL
may	NULL
be	NULL
relevant	NULL
to	NULL
the	NULL
role	NULL
of	NULL
MMTV	NULL
in	NULL
expression	NULL
of	NULL
MIs	NULL
antigens	NULL
or	NULL
the	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
lymphomas	NULL
.	NULL

Mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
(	NULL
MMTV	NULL
)	NULL
is	NULL
involved	NULL
in	NULL
at	NULL
least	NULL
three	NULL
different	NULL
biological	NULL
processes	NULL
:	NULL
induction	NULL
of	NULL
mammary	NULL
adenocarcinoma	NULL
,	NULL
generation	NULL
of	NULL
thymic	NULL
lymphoma	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
minor	NULL
histocompatibility	NULL
superantigens	NULL
of	NULL
the	NULL
Mls	NULL
type	NULL
.	NULL

The	NULL
relatively	NULL
large	NULL
and	NULL
complex	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
is	NULL
implicated	NULL
in	NULL
all	NULL
three	NULL
responses	NULL
.	NULL

Enhancers	NULL
in	NULL
the	NULL
LTR	NULL
activate	NULL
cellular	NULL
proto-oncogenes	NULL
to	NULL
induce	NULL
tumorigen-esis	NULL
in	NULL
mammary	NULL
tumors	NULL
(	NULL
1	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
MMTV	NULL
vari-	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
of	NULL
Canada	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
``	NULL
{	NULL
EMBL	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
U41642	NULL
.	NULL
}	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
408-492-3357	NULL
;	NULL
Fax	NULL
:	NULL
403-492-0886	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
MMTV	NULL
,	NULL
mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
;	NULL
AP1	NULL
,	NULL
AP2	NULL
,	NULL
and	NULL
AP3	NULL
,	NULL
activating	NULL
proteins	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
;	NULL
IL2	NULL
,	NULL
interleukin	NULL
2	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
META	NULL
,	NULL
MMTV	NULL
env	NULL
gene	NULL
transcriptional	NULL
activator	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor	NULL
k	NULL
B	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
;	NULL
TCEp	NULL
,	NULL
proximal	NULL
T	NULL
cell	NULL
element	NULL
;	NULL
tk	NULL
,	NULL
thymidine	NULL
kinase	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
MES	NULL
,	NULL
4A-morpholineethanesulfonic	NULL
acid	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporine	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

ants	NULL
that	NULL
induce	NULL
T	NULL
lymphomas	NULL
rather	NULL
than	NULL
mammary	NULL
adeno-carcinomas	NULL
carry	NULL
large	NULL
deletions	NULL
of	NULL
LTR	NULL
sequences	NULL
(	NULL
2	NULL
)	NULL
,	NULL
whose	NULL
absence	NULL
or	NULL
modification	NULL
is	NULL
necessary	NULL
for	NULL
T	NULL
cell	NULL
tumors	NULL
to	NULL
develop	NULL
(	NULL
3	NULL
)	NULL
.	NULL

And	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
minor	NULL
Mls	NULL
antigens	NULL
,	NULL
the	NULL
LTR	NULL
encodes	NULL
the	NULL
protein	NULL
antigen	NULL
in	NULL
one	NULL
of	NULL
several	NULL
forms	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

In	NULL
each	NULL
of	NULL
these	NULL
three	NULL
systems	NULL
,	NULL
there	NULL
is	NULL
a	NULL
requirement	NULL
for	NULL
MMTV-related	NULL
transcriptional	NULL
activity	NULL
in	NULL
lymphocytes	NULL
,	NULL
although	NULL
the	NULL
molecular	NULL
mechanisms	NULL
regulating	NULL
transcription	NULL
control	NULL
may	NULL
differ	NULL
between	NULL
them	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
expression	NULL
in	NULL
lymphocytes	NULL
includes	NULL
the	NULL
induction	NULL
of	NULL
tumors	NULL
by	NULL
the	NULL
mammotropic	NULL
strains	NULL
of	NULL
MMTV	NULL
,	NULL
as	NULL
part	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
transmission	NULL
to	NULL
the	NULL
mammary	NULL
epithelium	NULL
.	NULL

This	NULL
participation	NULL
requires	NULL
expression	NULL
of	NULL
the	NULL
virally	NULL
encoded	NULL
MIs	NULL
antigen	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
LTR	NULL
contains	NULL
strong	NULL
,	NULL
corticosteroid-inducible	NULL
transcriptional	NULL
activator	NULL
elements	NULL
(	NULL
7	NULL
)	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
what	NULL
their	NULL
role	NULL
is	NULL
,	NULL
if	NULL
any	NULL
,	NULL
in	NULL
transcriptional	NULL
control	NULL
in	NULL
lymphocytes	NULL
.	NULL

The	NULL
LTR	NULL
of	NULL
MMTV	NULL
resembles	NULL
that	NULL
of	NULL
other	NULL
retroviruses	NULL
in	NULL
that	NULL
it	NULL
contains	NULL
the	NULL
transcriptional	NULL
control	NULL
elements	NULL
and	NULL
start	NULL
site	NULL
for	NULL
viral	NULL
RNA	NULL
synthesis	NULL
.	NULL

We	NULL
have	NULL
described	NULL
a	NULL
second	NULL
,	NULL
novel	NULL
promoter	NULL
located	NULL
in	NULL
the	NULL
env	NULL
gene	NULL
of	NULL
MMTV	NULL
,	NULL
which	NULL
is	NULL
activated	NULL
in	NULL
certain	NULL
T	NULL
lymphoma	NULL
cell	NULL
lines	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
promoter	NULL
generates	NULL
transcripts	NULL
of	NULL
the	NULL
LTR	NULL
found	NULL
in	NULL
the	NULL
mouse	NULL
EL4.E1	NULL
cell	NULL
line	NULL
(	NULL
8	NULL
,	NULL
14	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
amplified	NULL
genomic	NULL
copies	NULL
of	NULL
MMTV	NULL
provirus	NULL
contain	NULL
a	NULL
large	NULL
deletion	NULL
typical	NULL
of	NULL
these	NULL
lymphomas	NULL
.	NULL

The	NULL
starting	NULL
point	NULL
of	NULL
the	NULL
transcript	NULL
lies	NULL
at	NULL
position	NULL
7247	NULL
in	NULL
the	NULL
MMTV	NULL
map	NULL
,	NULL
within	NULL
the	NULL
env	NULL
gene	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
.	NULL

The	NULL
relevant	NULL
promoter	NULL
is	NULL
apparently	NULL
controlled	NULL
by	NULL
the	NULL
sequence	NULL
immediately	NULL
upstream	NULL
of	NULL
it	NULL
in	NULL
the	NULL
env	NULL
gene	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
411-bp	NULL
env	NULL
gene	NULL
segment	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
,	NULL
which	NULL
we	NULL
term	NULL
META	NULL
(	NULL
for	NULL
MMTV	NULL
env	NULL
transcriptional	NULL
activator	NULL
)	NULL
was	NULL
established	NULL
by	NULL
transient	NULL
transfection	NULL
experiments	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
it	NULL
was	NULL
further	NULL
shown	NULL
that	NULL
this	NULL
activity	NULL
resembled	NULL
closely	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
(	NULL
IL2	NULL
)	NULL
promoter	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
.	NULL

It	NULL
was	NULL
restricted	NULL
to	NULL
T	NULL
helper	NULL
lymphocytes	NULL
,	NULL
it	NULL
was	NULL
dependent	NULL
on	NULL
cellular	NULL
activation	NULL
through	NULL
antigen	NULL
receptors	NULL
or	NULL
their	NULL
mimics	NULL
,	NULL
and	NULL
its	NULL
induction	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
drug	NULL
cyclosporine	NULL
(	NULL
CsA	NULL
)	NULL
.	NULL

META	NULL
was	NULL
active	NULL
in	NULL
mouse	NULL
and	NULL
human	NULL
T	NULL
lymphocyte	NULL
cell	NULL
lines	NULL
that	NULL
resemble	NULL
T	NULL
helper	NULL
cells	NULL
by	NULL
being	NULL
inducible	NULL
for	NULL
lymphokine	NULL
synthesis	NULL
,	NULL
including	NULL
mouse	NULL
EL4.E1	NULL
cells	NULL
,	NULL
a	NULL
mouse	NULL
T	NULL
hybridoma	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
the	NULL
human	NULL
Jurkat	NULL
cell	NULL
line	NULL
.	NULL

It	NULL
was	NULL
not	NULL
active	NULL
in	NULL
Hela	NULL
cells	NULL
,	NULL
or	NULL
,	NULL
under	NULL
the	NULL
conditions	NULL
studied	NULL
,	NULL
in	NULL
a	NULL
mouse	NULL
B	NULL
cell	NULL
line	NULL
or	NULL
a	NULL
cyto-toxic	NULL
T	NULL
lymphocyte	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
env	NULL
gene	NULL
was	NULL
shown	NULL
to	NULL
contain	NULL
both	NULL
a	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
start	NULL
site	NULL
for	NULL
mRNA	NULL
synthesis	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
META	NULL
for	NULL
interactions	NULL
with	NULL
activation-induced	NULL
DNA-binding	NULL
factors	NULL
and	NULL
have	NULL
identified	NULL
an	NULL
element	NULL
that	NULL
can	NULL
account	NULL
for	NULL
the	NULL
transcriptional	NULL
control	NULL
properties	NULL
of	NULL
the	NULL
env	NULL
gene	NULL
itself	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
META	NULL
promoter	NULL
resembles	NULL
the	NULL
activation	NULL
of	NULL
IL2	NULL
transcription	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
IL2	NULL
gene	NULL
in	NULL
T	NULL
helper	NULL
lymphocytes	NULL
is	NULL
controlled	NULL
primarily	NULL
by	NULL
the	NULL
sequence	NULL
lying	NULL
within	NULL
300	NULL
bp	NULL
upstream	NULL
8942	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
T	NULL
Cell-specific	NULL
Enhancer	NULL
in	NULL
MMTV	NULL
env	NULL
Gene	NULL
8943	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Several	NULL
transcription	NULL
factors	NULL
interact	NULL
with	NULL
this	NULL
region	NULL
,	NULL
including	NULL
AP1	NULL
,	NULL
AP3	NULL
,	NULL
Oct-1	NULL
,	NULL
NF-kB	NULL
,	NULL
and	NULL
NFAT	NULL
(	NULL
13	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NFAT	NULL
sites	NULL
show	NULL
activation-dependent	NULL
binding	NULL
with	NULL
their	NULL
relevant	NULL
factors	NULL
in	NULL
vivo	NULL
(	NULL
19	NULL
)	NULL
.	NULL

NFAT	NULL
is	NULL
the	NULL
most	NULL
sensitive	NULL
of	NULL
these	NULL
sites	NULL
to	NULL
CsA	NULL
,	NULL
as	NULL
its	NULL
binding	NULL
factor	NULL
is	NULL
completely	NULL
blocked	NULL
by	NULL
the	NULL
drug	NULL
.	NULL

Both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP3	NULL
are	NULL
somewhat	NULL
less	NULL
sensitive	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
META	NULL
region	NULL
contains	NULL
several	NULL
transcription	NULL
factor	NULL
binding	NULL
motifs	NULL
,	NULL
but	NULL
none	NULL
with	NULL
the	NULL
exact	NULL
NFAT	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IL2	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1c	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
an	NULL
element	NULL
could	NULL
be	NULL
identified	NULL
that	NULL
accounted	NULL
for	NULL
the	NULL
characteristic	NULL
transcriptional	NULL
activating	NULL
properties	NULL
of	NULL
META	NULL
.	NULL

This	NULL
paper	NULL
describes	NULL
in	NULL
detail	NULL
such	NULL
an	NULL
element	NULL
,	NULL
which	NULL
we	NULL
term	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells-Jurkat	NULL
(	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
)	NULL
,	NULL
EL4.E1	NULL
(	NULL
mouse	NULL
T-lympho-ma	NULL
)	NULL
,	NULL
8194	NULL
(	NULL
mouse	NULL
myeloma	NULL
)	NULL
,	NULL
and	NULL
Helia	NULL
(	NULL
endothelial	NULL
carcinoma	NULL
)	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
RHFM	NULL
medium	NULL
comprising	NULL
RPMI	NULL
1640	NULL
,	NULL
20	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
100	NULL
uM	NULL
2-mercaptoethanol	NULL
,	NULL
antibiotics	NULL
,	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts-Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
4-6	NULL
h	NULL
with	NULL
15	NULL
ng/ml	NULL
12-phorbol	NULL
13-myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
plus	NULL
1.5	NULL
um	NULL
ionomycin	NULL
,	NULL
or	NULL
with	NULL
PMA	NULL
plus	NULL
0.5	NULL
pm	NULL
A23187	NULL
.	NULL

IL2	NULL
was	NULL
measured	NULL
by	NULL
bioassay	NULL
(	NULL
21	NULL
)	NULL
.	NULL

CsA	NULL
was	NULL
present	NULL
at	NULL
100	NULL
ng/ml	NULL
where	NULL
indicated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
lysolecithin	NULL
lysis	NULL
method	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
aliquoted	NULL
,	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
in	NULL
cell	NULL
extracts	NULL
were	NULL
determined	NULL
with	NULL
a	NULL
Coomassie	NULL
protein	NULL
assay	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

DNA	NULL
Methodology	NULL
and	NULL
Reagents-Restriction	NULL
enzyme	NULL
digestions	NULL
,	NULL
DNA	NULL
polymerase	NULL
reactions	NULL
,	NULL
ligations	NULL
,	NULL
end	NULL
labeling	NULL
,	NULL
agarose	NULL
or	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
,	NULL
gel	NULL
elution	NULL
of	NULL
DNA	NULL
fragments	NULL
,	NULL
and	NULL
Sephadex	NULL
G-50	NULL
spin	NULL
column	NULL
chromatography	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
standard	NULL
protocols	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
DNA	NULL
synthesis	NULL
facilities	NULL
of	NULL
either	NULL
the	NULL
Departments	NULL
of	NULL
Microbiology	NULL
or	NULL
Biochemistry	NULL
at	NULL
the	NULL
University	NULL
of	NULL
Alberta	NULL
.	NULL

Molecular	NULL
biological	NULL
reagents	NULL
and	NULL
enzymes	NULL
were	NULL
obtained	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
(	NULL
Burlington	NULL
,	NULL
ON	NULL
)	NULL
,	NULL
the	NULL
luciferase	NULL
reporter	NULL
vector	NULL
pGL2	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
Maxam-Gilbert	NULL
chemical	NULL
sequencing	NULL
kit	NULL
from	NULL
DuPont	NULL
NEN	NULL
,	NULL
and	NULL
the	NULL
Maxi	NULL
Plasmid	NULL
DNA	NULL
purification	NULL
kit	NULL
from	NULL
Qiagen	NULL
Inc.	NULL
(	NULL
Charlesworth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
A23187	NULL
,	NULL
luciferin	NULL
,	NULL
acetyl	NULL
coenzyme	NULL
A	NULL
,	NULL
and	NULL
DNase	NULL
I	NULL
enzyme	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

CsA	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Sandoz	NULL
Canada	NULL
Inc.	NULL
(	NULL
Dorval	NULL
,	NULL
Quebec	NULL
)	NULL
.	NULL

DNA	NULL
sequences	NULL
were	NULL
amplified	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
using	NULL
primers	NULL
described	NULL
in	NULL
Table	NULL
I	NULL
,	NULL
carrying	NULL
the	NULL
prefixes	NULL
S	NULL
(	NULL
for	NULL
sense	NULL
orientation	NULL
)	NULL
and	NULL
A	NULL
(	NULL
for	NULL
antisense	NULL
)	NULL
.	NULL

Primers	NULL
and	NULL
templates	NULL
were	NULL
heat	NULL
denatured	NULL
and	NULL
annealed	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Typical	NULL
conditions	NULL
for	NULL
the	NULL
PCR	NULL
were	NULL
:	NULL
10	NULL
mx	NULL
Tris-HC	NULL
]	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
0.01	NULL
%	NULL
gelatin	NULL
,	NULL
3.0	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
dNTPs	NULL
,	NULL
80	NULL
nM	NULL
primers	NULL
,	NULL
6.25	NULL
ng	NULL
of	NULL
plasmid	NULL
template	NULL
,	NULL
and	NULL
1.25	NULL
units	NULL
of	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
,	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
50	NULL
ul	NULL
.	NULL

The	NULL
Hybaid	NULL
thermal	NULL
reactor	NULL
(	NULL
Bio/Can	NULL
Scientific	NULL
,	NULL
Toronto	NULL
,	NULL
ON	NULL
)	NULL
was	NULL
programmed	NULL
for	NULL
the	NULL
following	NULL
conditions	NULL
:	NULL
96	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
then	NULL
two	NULL
cycles	NULL
of	NULL
94	NULL
°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
45	NULL
°C	NULL
for	NULL
1	NULL
min	NULL
and	NULL
72	NULL
°C	NULL
for	NULL
1	NULL
min	NULL
;	NULL
followed	NULL
by	NULL
25	NULL
cycles	NULL
of	NULL
94	NULL
°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
60	NULL
°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
72	NULL
°C	NULL
for	NULL
1	NULL
min	NULL
;	NULL
and	NULL
ending	NULL
with	NULL
an	NULL
extension	NULL
reaction	NULL
at	NULL
72	NULL
°C	NULL
for	NULL
3	NULL
min	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
separated	NULL
by	NULL
PAGE	NULL
in	NULL
1	NULL
x	NULL
TBE	NULL
(	NULL
89	NULL
mm	NULL
Tris	NULL
,	NULL
89	NULL
mM	NULL
borie	NULL
acid	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Plasmids-Numbering	NULL
of	NULL
META	NULL
segments	NULL
is	NULL
based	NULL
on	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
of	NULL
the	NULL
META-driven	NULL
promoter	NULL
in	NULL
MMTV	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Construction	NULL
of	NULL
the	NULL
plasmid	NULL
pBLCAT2-C30	NULL
containing	NULL
META	NULL
sequences	NULL
from	NULL
-29	NULL
to	NULL
-4839	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
has	NULL
been	NULL
described	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Plasmids	NULL
pGL2	NULL
promoter	NULL
and	NULL
control	NULL
vectors	NULL
are	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
containing	NULL
the	NULL
SV40	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
SV40	NULL
promoter	NULL
plus	NULL
enhancer	NULL
,	NULL
respectively	NULL
.	NULL

Plasmid	NULL
pDS-tk13	NULL
has	NULL
the	NULL
thymidine	NULL
kinase	NULL
(	NULL
tk	NULL
)	NULL
promoter	NULL
in	NULL
place	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
in	NULL
the	NULL
pGL2	NULL
promoter	NULL
vector	NULL
background	NULL
,	NULL
and	NULL
was	NULL
constructed	NULL
as	NULL
follows	NULL
.	NULL

Plasmids	NULL
pBLCAT2-C30	NULL
and	NULL
pGL2	NULL
promoter	NULL
vectors	NULL
were	NULL
digested	NULL
with	NULL
BgilI	NULL
and	NULL
HindIII	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
recessed	NULL
ends	NULL
were	NULL
filled	NULL
in	NULL
using	NULL
the	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
enzyme	NULL
.	NULL

Linearized	NULL
,	NULL
blunt-ended	NULL
pBLCAT-C30	NULL
was	NULL
cut	NULL
with	NULL
BamHI	NULL
to	NULL
yield	NULL
the	NULL
411-bp	NULL
META	NULL
fragment	NULL
,	NULL
a	NULL
168-bp	NULL
tk	NULL
promoter	NULL
fragment	NULL
,	NULL
and	NULL
a	NULL
4.3-kb	NULL
vector	NULL
DNA	NULL
fragment	NULL
.	NULL

Digestion	NULL
of	NULL
the	NULL
linearized	NULL
,	NULL
blunt-ended	NULL
pGL2	NULL
promoter	NULL
vector	NULL
with	NULL
Bg/II	NULL
yielded	NULL
a	NULL
203-bp	NULL
fragment	NULL
containing	NULL
the	NULL
SV40	NULL
promoter	NULL
and	NULL
5.59-kb	NULL
vector	NULL
DNA	NULL
fragment	NULL
.	NULL

The	NULL
tk	NULL
promoter	NULL
fragment	NULL
generated	NULL
from	NULL
pBLCAT-30	NULL
,	NULL
and	NULL
the	NULL
linearized	NULL
pGL2	NULL
vector	NULL
segment	NULL
lacking	NULL
the	NULL
SV40	NULL
promoter	NULL
were	NULL
purified	NULL
on	NULL
agarose	NULL
gels	NULL
and	NULL
ligated	NULL
to	NULL
yield	NULL
the	NULL
pDS-tk13	NULL
enhancerless	NULL
luciferase	NULL
reporter	NULL
vector	NULL
.	NULL

A	NULL
number	NULL
of	NULL
double-stranded	NULL
DNAs	NULL
were	NULL
prepared	NULL
by	NULL
PCR	NULL
amplification	NULL
using	NULL
primers	NULL
described	NULL
in	NULL
Table	NULL
I.	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
DNA	NULL
with	NULL
protruding	NULL
5°	NULL
AA	NULL
(	NULL
821	NULL
)	NULL
and	NULL
TT	NULL
(	NULL
A21	NULL
)	NULL
termini	NULL
were	NULL
first	NULL
filled	NULL
in	NULL
using	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
and	NULL
then	NULL
blunt-end	NULL
ligated	NULL
for	NULL
16	NULL
h	NULL
at	NULL
14	NULL
°C	NULL
to	NULL
generate	NULL
multimers	NULL
.	NULL

These	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
in	NULL
pDS-tk13	NULL
to	NULL
generate	NULL
recombinant	NULL
plasmids	NULL
pDSD61	NULL
to	NULL
pDSD65	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
head-to-tail	NULL
configuration	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
segments	NULL
generated	NULL
a	NULL
Hpal	NULL
restriction	NULL
enzyme	NULL
site	NULL
,	NULL
which	NULL
was	NULL
used	NULL
in	NULL
conjunction	NULL
with	NULL
other	NULL
methods	NULL
to	NULL
determine	NULL
the	NULL
orientation	NULL
and	NULL
copy	NULL
number	NULL
of	NULL
D	NULL
(	NULL
+	NULL
)	NULL
enhancer	NULL
constructs	NULL
(	NULL
head-to-head	NULL
and	NULL
tail-to-tail	NULL
configurations	NULL
lack	NULL
the	NULL
Apel	NULL
site	NULL
)	NULL
.	NULL

Plasmid	NULL
pDSM25F	NULL
is	NULL
a	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
derived	NULL
from	NULL
pDS-tk13	NULL
harboring	NULL
the	NULL
META	NULL
fragment	NULL
extending	NULL
from	NULL
-29	NULL
to	NULL
-429	NULL
upstream	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
.	NULL

The	NULL
complete	NULL
META	NULL
fragment	NULL
(	NULL
411	NULL
bp	NULL
)	NULL
was	NULL
liberated	NULL
from	NULL
pBLCAT2-C30	NULL
by	NULL
Sail	NULL
digestion	NULL
,	NULL
purified	NULL
by	NULL
PAGE	NULL
,	NULL
and	NULL
ligated	NULL
into	NULL
Xhol-cut	NULL
pDS-tk13	NULL
to	NULL
generate	NULL
pDSM25F	NULL
.	NULL

Human	NULL
genomic	NULL
IL2	NULL
sequences	NULL
from	NULL
-98	NULL
to	NULL
-362	NULL
or	NULL
from	NULL
+45	NULL
to	NULL
-180	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
primer	NULL
pairs	NULL
S17	NULL
and	NULL
A17	NULL
(	NULL
for	NULL
-98	NULL
to	NULL
-362	NULL
)	NULL
or	NULL
S16	NULL
and	NULL
A16	NULL
(	NULL
for	NULL
+45	NULL
to	NULL
-180	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
hIL2	NULL
PCR	NULL
product	NULL
for	NULL
-98	NULL
to	NULL
-362	NULL
region	NULL
was	NULL
gel-purified	NULL
,	NULL
digested	NULL
with	NULL
EcoR	NULL
I	NULL
and	NULL
HindIII	NULL
,	NULL
and	NULL
ligated	NULL
into	NULL
pGEM-3Z	NULL
vector	NULL
cut	NULL
with	NULL
EcoRI	NULL
and	NULL
HindIII	NULL
.	NULL

The	NULL
ligation	NULL
mixture	NULL
was	NULL
transformed	NULL
into	NULL
Escherichia	NULL
coli	NULL
DHS	NULL
,	NULL
and	NULL
plated	NULL
on	NULL
LB	NULL
agar-ampicillin	NULL
indicator	NULL
plates	NULL
containing	NULL
5-bromo-4-chloro-3-indoyl	NULL
B-D-galactoside	NULL
and	NULL
isopropyl-l-thio-B-D-galactopyranoside	NULL
for	NULL
blue/white	NULL
colony	NULL
selection	NULL
.	NULL

White	NULL
colonies	NULL
were	NULL
selected	NULL
,	NULL
and	NULL
the	NULL
recombinant	NULL
plasmid	NULL
pDIL2	NULL
thus	NULL
generated	NULL
was	NULL
purified	NULL
and	NULL
sequenced	NULL
.	NULL

Recombinant	NULL
constructs	NULL
were	NULL
confirmed	NULL
by	NULL
both	NULL
sequencing	NULL
and/or	NULL
restriction	NULL
digestion	NULL
analysis	NULL
.	NULL

DNase	NULL
I	NULL
Footprint	NULL
Analysis-Plasmid	NULL
pBLCAT2-C30	NULL
was	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
META	NULL
(	NULL
-439	NULL
to	NULL
-29	NULL
,	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
.	NULL

For	NULL
upper	NULL
strand	NULL
labeling	NULL
,	NULL
the	NULL
plasmid	NULL
was	NULL
linearized	NULL
with	NULL
Xbal	NULL
,	NULL
dephosphorylated	NULL
,	NULL
and	NULL
end-labeled	NULL
using	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
I.	NULL
Radiolabeled	NULL
DNA	NULL
was	NULL
separated	NULL
from	NULL
unincorporated	NULL
label	NULL
on	NULL
a	NULL
Sephadex	NULL
G50	NULL
spin	NULL
column	NULL
.	NULL

Psfl	NULL
digestion	NULL
of	NULL
this	NULL
DNA	NULL
resulted	NULL
in	NULL
528-bp	NULL
labeled	NULL
META	NULL
fragment	NULL
with	NULL
flanking	NULL
vector	NULL
sequences	NULL
,	NULL
a	NULL
9-bp	NULL
labeled	NULL
Psfl-Xbal	NULL
fragment	NULL
from	NULL
the	NULL
multicloning	NULL
site	NULL
,	NULL
and	NULL
the	NULL
remaining	NULL
4363-bp	NULL
vector	NULL
DNA	NULL
.	NULL

The	NULL
lower	NULL
strand	NULL
of	NULL
META	NULL
was	NULL
labeled	NULL
at	NULL
the	NULL
XbaI	NULL
end	NULL
starting	NULL
with	NULL
pBLCAT2-C30	NULL
containing	NULL
META	NULL
(	NULL
-29	NULL
to	NULL
-489	NULL
)	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
.	NULL

HindIII	NULL
digestion	NULL
of	NULL
this	NULL
DNA	NULL
resulted	NULL
in	NULL
the	NULL
release	NULL
of	NULL
a	NULL
406-bp	NULL
labeled	NULL
META	NULL
fragment	NULL
along	NULL
with	NULL
labeled	NULL
20-bp	NULL
Xbal-HindlIlI	NULL
fragment	NULL
from	NULL
the	NULL
multicloning	NULL
site	NULL
and	NULL
the	NULL
4485-bp	NULL
of	NULL
the	NULL
vector	NULL
DNA	NULL
.	NULL

The	NULL
labeled	NULL
META	NULL
DNA	NULL
along	NULL
with	NULL
the	NULL
vector	NULL
DNA	NULL
fragments	NULL
obtained	NULL
by	NULL
these	NULL
procedures	NULL
was	NULL
used	NULL
without	NULL
further	NULL
fractionation	NULL
.	NULL

Binding	NULL
reactions	NULL
and	NULL
DNase	NULL
I	NULL
digestions	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
room	NULL
temperature	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
DNase	NULL
I	NULL
footprinting	NULL
manual	NULL
,	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
assay	NULL
system	NULL
contained	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
2	NULL
mm	NULL
CaCl	NULL
,	NULL
,	NULL
0.5	NULL
mm	NULL
DTT	NULL
,	NULL
0.5	NULL
mm	NULL
phenyImethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
30	NULL
mM	NULL
KCl	NULL
,	NULL
2.5	NULL
ug/ml	NULL
bovine	NULL
serum	NULL
,	NULL
0.5	NULL
%	NULL
glycerol	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
Jurkat	NULL
cell	NULL
nuclear	NULL
protein	NULL
,	NULL
and	NULL
2	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
a	NULL
reaction	NULL
volume	NULL
of	NULL
50	NULL
ul	NULL
.	NULL

Reactions	NULL
were	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ng	NULL
of	NULL
DNA	NULL
probe	NULL
(	NULL
20,000	NULL
cpm	NULL
)	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
incubation	NULL
of	NULL
20	NULL
min	NULL
,	NULL
50	NULL
Ll	NULL
of	NULL
DNase	NULL
I	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
CaCl	NULL
,	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
50	NULL
ng	NULL
of	NULL
DNase	NULL
I.	NULL
Digestion	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
10	NULL
wl	NULL
of	NULL
stop	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
MES	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
15	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
250	NULL
pg	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
proteinase	NULL
K	NULL
)	NULL
.	NULL

Proteinase	NULL
K	NULL
digestion	NULL
was	NULL
continued	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
extracted	NULL
with	NULL
phenol	NULL
:	NULL
chloroform	NULL
:	NULL
isoamyl	NULL
alcohol	NULL
(	NULL
25:24:1	NULL
)	NULL
,	NULL
precipitated	NULL
using	NULL
ethanol	NULL
and	NULL
sodium	NULL
acetate	NULL
,	NULL
dissolved	NULL
in	NULL
formamide	NULL
loading	NULL
buffer	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
6	NULL
%	NULL
acrylamide	NULL
,	NULL
7	NULL
M	NULL
urea	NULL
PAGE	NULL
(	NULL
0.4	NULL
mm	NULL
thick	NULL
gel	NULL
)	NULL
in	NULL
1	NULL
X	NULL
TBE	NULL
buffer	NULL
using	NULL
a	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
vertical	NULL
gel	NULL
apparatus	NULL
.	NULL

Dried	NULL
gels	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
film	NULL
at	NULL
-70	NULL
°C	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Mobility	NULL
Shift	NULL
Assays-Single-stranded	NULL
oligonucleotides	NULL
(	NULL
sense	NULL
strands	NULL
)	NULL
were	NULL
end-labeled	NULL
using	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
JATP	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
the	NULL
kinase	NULL
was	NULL
heat-denatured	NULL
,	NULL
and	NULL
the	NULL
fragments	NULL
were	NULL
annealed	NULL
to	NULL
complementary	NULL
antisense	NULL
oligonucleotides	NULL
.	NULL

Unincorporated	NULL
label	NULL
was	NULL
separated	NULL
on	NULL
G-50	NULL
Sephadex	NULL
spin	NULL
columns	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
0.5	NULL
nM	NULL
probe	NULL
(	NULL
5,000-10,000	NULL
cpm	NULL
)	NULL
in	NULL
a	NULL
final	NULL
reaction	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Reaction	NULL
mixtures	NULL
contained	NULL
25	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
75	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
DTT	NULL
,	NULL
0.5	NULL
mm	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
3	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
Jurkat	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mix	NULL
after	NULL
10	NULL
min	NULL
,	NULL
or	NULL
a	NULL
total	NULL
of	NULL
25	NULL
min	NULL
when	NULL
cold	NULL
competitor	NULL
DNA	NULL
was	NULL
included	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
then	NULL
continued	NULL
for	NULL
30	NULL
min	NULL
,	NULL
analyzed	NULL
on	NULL
4	NULL
%	NULL
acrylamide	NULL
(	NULL
1.5-mm-thick	NULL
gels	NULL
)	NULL
in	NULL
1	NULL
X	NULL
TBE	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Dried	NULL
gels	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
film	NULL
at	NULL
-70	NULL
°C	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
8944	NULL
T	NULL
Cell-specific	NULL
Enhancer	NULL
in	NULL
MMTV	NULL
env	NULL
Gene	NULL
PMA-induced	NULL
MMTV	NULL
RNA	NULL
transcript	NULL
pro	NULL
pol	NULL
|env	NULL
3	NULL
LTR	NULL
a	NULL
]	NULL
)	NULL
MMTV	NULL
1	NULL
6801-7212	NULL
Xba	NULL
/Sal	NULL
I	NULL
Pst	NULL
/Sph	NULL
Hind	NULL
III	NULL
b	NULL
pBLCAT2	NULL
-	NULL
C30	NULL
BamHI	NULL
-	NULL
BamHI	NULL
C	NULL
-	NULL
GaceggATee	NULL
CaaGCTTTeT	NULL
TeTerercer	NULL
ceeccccece_ccreTeacee	NULL
-395	NULL
BamH	NULL
I	NULL
M-AP2	NULL
Preceomtac	NULL
CraccTaAAc	NULL
caccraTror	NULL
ccatfccore	NULL
-345	NULL
Asa	NULL
I	NULL
--	NULL
3	NULL
ceareemmaac	NULL
TAcacaceec	NULL
)	NULL
afrracaerrc	NULL
Teaccaatca	NULL
AaccatGrar	NULL
-295	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
METAD	NULL
]	NULL
)	NULL
Treserceer	NULL
Coccreactt	NULL
TCACGGGTTT	NULL
AAAAACATGT	NULL
CTGGcAATGT	NULL
-245	NULL
M-AP3/TCEp	NULL
ACATTTTGAG	NULL
GGGAAGTCTG	NULL
ATACGCTCCC	NULL
CATTTGCITT	NULL
TCCTPCTCCT	NULL
-195	NULL
M-Pu	NULL
Box	NULL
TTTCTACCCC	NULL
CACGGGCTGC	NULL
TTTCAAGTAG	NULL
ATAAGCAAGT	NULL
ATTTCTTTCE	NULL
-145	NULL
GATACACCCA	NULL
CGCTTGATAA	NULL
TAATAAACCT|	NULL
GGGGGAAAGA	NULL
_	NULL
CTGATAAAAG	NULL
-95	NULL
METAP	NULL
M-MAF	NULL
GCGTATGTGG	NULL
AAACTTTGGT	NULL
TGACTACTTT	NULL
AGAGAACTCA	NULL
GGGGCCAATA	NULL
-45	NULL
M-AP3	NULL
CAAAACTGGT	NULL
Cgacatggat	NULL
cc	NULL
-24	NULL
BamH	NULL
I	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Structure	NULL
of	NULL
META	NULL
.	NULL

The	NULL
9.9-kb	NULL
MMTV	NULL
genome	NULL
is	NULL
represented	NULL
in	NULL
a	NULL
,	NULL
with	NULL
the	NULL
META	NULL
segment	NULL
located	NULL
in	NULL
the	NULL
env	NULL
gene	NULL
.	NULL

The	NULL
LTRs	NULL
(	NULL
1328	NULL
bp	NULL
)	NULL
contain	NULL
the	NULL
conventional	NULL
MMTV	NULL
promoter	NULL
,	NULL
responsible	NULL
for	NULL
the	NULL
synthesis	NULL
of	NULL
MMTV	NULL
RNA	NULL
,	NULL
which	NULL
originates	NULL
near	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
5	NULL
'	NULL
LTR	NULL
.	NULL

The	NULL
MMTV	NULL
provirus	NULL
from	NULL
which	NULL
META	NULL
was	NULL
first	NULL
isolated	NULL
,	NULL
derived	NULL
from	NULL
EL4.E1	NULL
T	NULL
lymphoma	NULL
cells	NULL
,	NULL
carried	NULL
a	NULL
494-bp	NULL
deletion	NULL
within	NULL
the	NULL
LTR	NULL
,	NULL
indicated	NULL
by	NULL
the	NULL
shaded	NULL
box	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

META	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
activation-dependent	NULL
,	NULL
CsA-suppressible	NULL
transcription	NULL
described	NULL
earlier	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
which	NULL
originates	NULL
within	NULL
the	NULL
env	NULL
gene	NULL
and	NULL
copies	NULL
the	NULL
3	NULL
'	NULL
LTR	NULL
.	NULL

b	NULL
,	NULL
pBLCAT2-C30	NULL
is	NULL
a	NULL
plasmid	NULL
in	NULL
which	NULL
a	NULL
META	NULL
sequence	NULL
lacking	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
was	NULL
cloned	NULL
as	NULL
a	NULL
BamHI	NULL
insert	NULL
upstream	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
tk	NULL
promoter	NULL
and	NULL
the	NULL
CAT	NULL
coding	NULL
region	NULL
(	NULL
9	NULL
)	NULL
.	NULL

It	NULL
represents	NULL
segment	NULL
6814-7212	NULL
of	NULL
MMTV	NULL
.	NULL

c	NULL
,	NULL
the	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
META-BamHI	NULL
fragment	NULL
in	NULL
pBLCAT2-C30	NULL
,	NULL
and	NULL
derived	NULL
plasmids	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Sequence	NULL
numbering	NULL
here	NULL
is	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
within	NULL
META	NULL
,	NULL
which	NULL
occurs	NULL
at	NULL
position	NULL
7246	NULL
of	NULL
the	NULL
milk-borne	NULL
virus	NULL
sequence	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Nucleotide	NULL
positions	NULL
at	NULL
the	NULL
ends	NULL
of	NULL
the	NULL
fragment	NULL
that	NULL
were	NULL
altered	NULL
to	NULL
generate	NULL
restriction	NULL
enzyme	NULL
sites	NULL
are	NULL
shown	NULL
in	NULL
lowercase	NULL
.	NULL

The	NULL
underlined	NULL
segments	NULL
represent	NULL
restriction	NULL
enzyme	NULL
sites	NULL
(	NULL
thin	NULL
line	NULL
)	NULL
and	NULL
sequence	NULL
motifs	NULL
that	NULL
are	NULL
candidates	NULL
for	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
(	NULL
Reavy	NULL
underline	NULL
)	NULL
.	NULL

The	NULL
potential	NULL
binding	NULL
sequences	NULL
,	NULL
labeled	NULL
``	NULL
M-	NULL
``	NULL
(	NULL
for	NULL
motif	NULL
)	NULL
,	NULL
were	NULL
identified	NULL
based	NULL
on	NULL
their	NULL
similarity	NULL
to	NULL
the	NULL
consensus	NULL
binding	NULL
sequences	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
indicated	NULL
(	NULL
11	NULL
)	NULL
:	NULL
AP2	NULL
and	NULL
AP3	NULL
(	NULL
activating	NULL
proteins	NULL
2	NULL
and	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
;	NULL
MAF	NULL
,	NULL
mammary	NULL
cell	NULL
activating	NULL
factor	NULL
(	NULL
12	NULL
)	NULL
;	NULL
TCEp	NULL
,	NULL
proximal	NULL
T	NULL
cell	NULL
element	NULL
of	NULL
the	NULL
IL2	NULL
gene	NULL
(	NULL
13	NULL
)	NULL
;	NULL
Pu	NULL
box	NULL
,	NULL
proximal	NULL
purine	NULL
box	NULL
of	NULL
mouse	NULL
or	NULL
human	NULL
IL2	NULL
enhancer	NULL
.	NULL

Regions	NULL
identified	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
are	NULL
delineated	NULL
by	NULL
boxes	NULL
(	NULL
META	NULL
D	NULL
segments	NULL
,	NULL
META	NULL
P	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
text	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
shown	NULL
here	NULL
is	NULL
derived	NULL
from	NULL
the	NULL
MMTV	NULL
provirus	NULL
(	NULL
clone	NULL
C30	NULL
)	NULL
used	NULL
in	NULL
this	NULL
and	NULL
previous	NULL
work	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
and	NULL
differs	NULL
slightly	NULL
from	NULL
that	NULL
of	NULL
the	NULL
milk-borne	NULL
virus	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
Measurement	NULL
of	NULL
Luciferase	NULL
Activity-Purified	NULL
plasmid	NULL
DNA	NULL
that	NULL
was	NULL
>	NULL
90	NULL
%	NULL
closed	NULL
circular	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
gel	NULL
analysis	NULL
and	NULL
ethidium	NULL
bromide	NULL
fluorescence	NULL
quantitation	NULL
(	NULL
27	NULL
)	NULL
was	NULL
used	NULL
in	NULL
the	NULL
DEAE-dextran	NULL
transfection	NULL
protocol	NULL
(	NULL
9	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
15	NULL
ug	NULL
of	NULL
DNA	NULL
was	NULL
used	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
2	NULL
ml	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
resus-pended	NULL
,	NULL
divided	NULL
,	NULL
and	NULL
maintained	NULL
in	NULL
RHFM	NULL
medium	NULL
for	NULL
36-42	NULL
h.	NULL
Cells	NULL
were	NULL
induced	NULL
for	NULL
6	NULL
h	NULL
by	NULL
adding	NULL
PMA	NULL
plus	NULL
A23187	NULL
with	NULL
or	NULL
without	NULL
CsA	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
:	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
25	NULL
mm	NULL
glycylglycine	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
15	NULL
mm	NULL
MgSQO	NULL
,	NULL
,	NULL
4	NULL
mM	NULL
EGTA	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
DTT	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Luciferase	NULL
activities	NULL
in	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Promega	NULL
luciferase	NULL
assay	NULL
manual	NULL
using	NULL
a	NULL
Lumat	NULL
LB	NULL
9501	NULL
luminometer	NULL
.	NULL

A	NULL
sent	NULL
B	NULL
M	NULL
*~	NULL
P	NULL
-296	NULL
-296	NULL
-146r	NULL
DC	NULL
)	NULL
p	NULL
I	NULL
-325	NULL
U|	NULL
D	NULL
(	NULL
+	NULL
)	NULL
“	NULL
1	NULL
1	NULL
6	NULL
_350	NULL
~388	NULL
-so	NULL
1	NULL
418	NULL
1	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
of	NULL
META	NULL
.	NULL

The	NULL
lower	NULL
(	NULL
4	NULL
)	NULL
or	NULL
the	NULL
upper	NULL
(	NULL
B	NULL
)	NULL
strand	NULL
of	NULL
META	NULL
was	NULL
end-labeled	NULL
and	NULL
subjected	NULL
to	NULL
DNase	NULL
I	NULL
digestion	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
Jurkat	NULL
cells	NULL
(	NULL
-	NULL
)	NULL
,	NULL
or	NULL
cells	NULL
stimulated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
A	NULL
)	NULL
or	NULL
PMA	NULL
plus	NULL
A23187	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
segments	NULL
differentially	NULL
protected	NULL
in	NULL
induced	NULL
and	NULL
uninduced	NULL
extracts	NULL
are	NULL
indicated	NULL
as	NULL
``	NULL
D	NULL
``	NULL
(	NULL
distal	NULL
)	NULL
or	NULL
``	NULL
P	NULL
``	NULL
(	NULL
proximal	NULL
)	NULL
on	NULL
the	NULL
line	NULL
representation	NULL
of	NULL
the	NULL
sequence	NULL
on	NULL
the	NULL
left	NULL
,	NULL
which	NULL
also	NULL
shows	NULL
the	NULL
location	NULL
of	NULL
the	NULL
label	NULL
(	NULL
*	NULL
)	NULL
.	NULL

Protected	NULL
regions	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
and	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
uninduced	NULL
and	NULL
induced	NULL
nuclear	NULL
extracts	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
region	NULL
P	NULL
was	NULL
found	NULL
to	NULL
be	NULL
weakly	NULL
protected	NULL
with	NULL
induced	NULL
extracts	NULL
.	NULL

N	NULL
,	NULL
no	NULL
nuclear	NULL
extract	NULL
;	NULL
@	NULL
,	NULL
G/A	NULL
,	NULL
and	NULL
T/C	NULL
indicate	NULL
Maxam-Gilbert	NULL
chemical	NULL
sequencing	NULL
reactions	NULL
.	NULL

The	NULL
luciferase	NULL
assay	NULL
contained	NULL
20	NULL
mM	NULL
glycylglycine	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
1	NULL
mM	NULL
Mg	NULL
(	NULL
CO	NULL
,	NULL
)	NULL
,	NULL
,	NULL
2.7	NULL
mm	NULL
MgSQO	NULL
,	NULL
,	NULL
0.1	NULL
mm	NULL
EDTA	NULL
,	NULL
33	NULL
mm	NULL
DTT	NULL
,	NULL
0.47	NULL
mM	NULL
luciferin	NULL
,	NULL
0.53	NULL
mM	NULL
ATP	NULL
,	NULL
and	NULL
0.27	NULL
mM	NULL
coenzyme	NULL
A	NULL
in	NULL
a	NULL
reaction	NULL
volume	NULL
of	NULL
100	NULL
al	NULL
.	NULL

RESULTS	NULL
DNA	NULL
Footprint	NULL
Analysis	NULL
of	NULL
the	NULL
Interaction	NULL
of	NULL
Nuclear	NULL
Factors	NULL
from	NULL
Jurkat	NULL
Cells	NULL
with	NULL
the	NULL
META	NULL
Sequence-The	NULL
complete	NULL
META	NULL
segment	NULL
of	NULL
MMTV	NULL
,	NULL
comprising	NULL
the	NULL
411-bp	NULL
region	NULL
lying	NULL
between	NULL
29	NULL
and	NULL
439	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
novel	NULL
env	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
inducible	NULL
,	NULL
CsA-suppressible	NULL
,	NULL
and	NULL
T	NULL
lymphocyte-specific	NULL
expression	NULL
of	NULL
reporter	NULL
genes	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
it	NULL
responds	NULL
in	NULL
parallel	NULL
with	NULL
lymphokine	NULL
enhancers	NULL
,	NULL
such	NULL
as	NULL
that	NULL
of	NULL
IL2	NULL
,	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
therefore	NULL
carried	NULL
out	NULL
DNase	NULL
I	NULL
footprinting	NULL
experiments	NULL
to	NULL
look	NULL
for	NULL
interactions	NULL
with	NULL
nuclear	NULL
factors	NULL
from	NULL
Jurkat	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
that	NULL
is	NULL
induced	NULL
to	NULL
synthesize	NULL
IL2	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
a	NULL
calcium	NULL
ionophore	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
,	NULL
were	NULL
examined	NULL
.	NULL

The	NULL
footprint	NULL
pattern	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
revealed	NULL
two	NULL
regions	NULL
of	NULL
protection	NULL
with	NULL
induced	NULL
extracts	NULL
,	NULL
compared	NULL
to	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
.	NULL

These	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
proximal	NULL
(	NULL
META	NULL
(	NULL
P	NULL
)	NULL
)	NULL
and	NULL
distal	NULL
(	NULL
META	NULL
(	NULL
D	NULL
)	NULL
)	NULL
.	NULL

META	NULL
(	NULL
P	NULL
)	NULL
is	NULL
located	NULL
around	NULL
-116	NULL
to	NULL
-146	NULL
relative	NULL
to	NULL
the	NULL
META	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

Extracts	NULL
from	NULL
induced	NULL
cells	NULL
showed	NULL
partial	NULL
or	NULL
faint	NULL
protection	NULL
of	NULL
this	NULL
region	NULL
,	NULL
compared	NULL
to	NULL
uninduced	NULL
cells	NULL
.	NULL

In	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
end-labeled	NULL
lower	NULL
strand	NULL
,	NULL
partial	NULL
protection	NULL
of	NULL
META	NULL
(	NULL
P	NULL
)	NULL
was	NULL
consistently	NULL
observed	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
META	NULL
(	NULL
D	NULL
)	NULL
comprised	NULL
two	NULL
strong	NULL
and	NULL
discrete	NULL
footprints	NULL
with	NULL
extracts	NULL
of	NULL
stimulated	NULL
cells	NULL
,	NULL
one	NULL
in	NULL
the	NULL
-296	NULL
to	NULL
-323	NULL
region	NULL
and	NULL
the	NULL
other	NULL
in	NULL
the	NULL
-325	NULL
to	NULL
-349	NULL
region	NULL
.	NULL

To	NULL
further	NULL
delineate	NULL
the	NULL
META	NULL
(	NULL
D	NULL
)	NULL
footprint	NULL
,	NULL
we	NULL
performed	NULL
DNase	NULL
I	NULL
digestions	NULL
using	NULL
the	NULL
upper	NULL
strand	NULL
of	NULL
META	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
footprint	NULL
pattern	NULL
in	NULL
the	NULL
META	NULL
(	NULL
D	NULL
)	NULL
region	NULL
showed	NULL
some	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
T	NULL
Cell-specific	NULL
Enhancer	NULL
in	NULL
MMTV	NULL
env	NULL
Gene	NULL
8945	NULL
TaBtE	NULL
I	NULL
Oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
Sequences	NULL
are	NULL
designated	NULL
by	NULL
a	NULL
prefix	NULL
``	NULL
8	NULL
``	NULL
(	NULL
sense	NULL
strand	NULL
)	NULL
or	NULL
``	NULL
A	NULL
``	NULL
(	NULL
antisense	NULL
)	NULL
,	NULL
and	NULL
are	NULL
shown	NULL
with	NULL
5°	NULL
to	NULL
3	NULL
'	NULL
polarity	NULL
,	NULL
left	NULL
to	NULL
right	NULL
.	NULL

Some	NULL
oligonucleotides	NULL
contain	NULL
5	NULL
'	NULL
leader	NULL
segments	NULL
,	NULL
introduced	NULL
for	NULL
convenience	NULL
of	NULL
manipulations	NULL
,	NULL
that	NULL
do	NULL
not	NULL
match	NULL
the	NULL
sequences	NULL
of	NULL
interest	NULL
.	NULL

These	NULL
are	NULL
given	NULL
in	NULL
lowercase	NULL
,	NULL
and	NULL
are	NULL
underlined	NULL
where	NULL
they	NULL
contain	NULL
restriction	NULL
sites	NULL
.	NULL

``	NULL
Position	NULL
of	NULL
5	NULL
nucleotide	NULL
``	NULL
refers	NULL
to	NULL
the	NULL
position	NULL
of	NULL
the	NULL
5	NULL
``	NULL
nucleotide	NULL
of	NULL
a	NULL
given	NULL
sequence	NULL
,	NULL
excluding	NULL
any	NULL
mismatching	NULL
leader	NULL
sequence	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
relevant	NULL
transcription	NULL
start	NULL
sites	NULL
in	NULL
META	NULL
.	NULL

The	NULL
sequences	NULL
were	NULL
derived	NULL
from	NULL
published	NULL
work	NULL
:	NULL
META	NULL
(	NULL
9	NULL
)	NULL
,	NULL
human	NULL
IL2	NULL
(	NULL
24	NULL
)	NULL
,	NULL
SV40	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
CTL-specific	NULL
protease	NULL
clone	NULL
C11	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Motifs	NULL
taken	NULL
from	NULL
published	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
included	NULL
NF-KB	NULL
,	NULL
NFAT	NULL
,	NULL
AP1	NULL
,	NULL
AP3/TCEp	NULL
,	NULL
and	NULL
Pu	NULL
box	NULL
(	NULL
9	NULL
,	NULL
11	NULL
,	NULL
13	NULL
)	NULL
and	NULL
MAF	NULL
(	NULL
12	NULL
)	NULL
.	NULL

D	NULL
(	NULL
+	NULL
)	NULL
and	NULL
D	NULL
(	NULL
-	NULL
)	NULL
motifs	NULL
described	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

Position	NULL
of	NULL
5	NULL
!	NULL

Oligonucleotide	NULL
nucleotide	NULL
Sequence	NULL
Motif	NULL
Human	NULL
IL2	NULL
S09	NULL
-210	NULL
CAAAGAGGGATTTCACCTACATCC	NULL
NF-	NULL
«	NULL
B	NULL
A10	NULL
-187	NULL
GGATGTAGGTGAAATCCCTCTTTG	NULL
NF-	NULL
«	NULL
B	NULL
S16	NULL
-180	NULL
gegaagetTCAGTCTTTGGGGGT	NULL
A16	NULL
+45	NULL
geggaattecGGCAGGAGTTGAGGT	NULL
S17	NULL
-362	NULL
geggaATTCACATGTTCAGTG	NULL
A17	NULL
-98	NULL
gegaagettGACTTTACCAGTCTG	NULL
822	NULL
-291	NULL
AGAAAGGAGGAAAAACTGTTTCATACAGAAGG	NULL
NFAT	NULL
A22	NULL
-260	NULL
CCTTCTGTATGAAACAGTTTTTCCTCCTTTCT	NULL
NFAT	NULL
META	NULL
S18	NULL
-278	NULL
ACTTTCACGGGTTTAAAAACATGTCT	NULL
AP3/TCEp	NULL
A18	NULL
-253	NULL
AGACATGTTTTTAAACCCGTGAAAGT	NULL
AP3/TCEp	NULL
S19	NULL
-215	NULL
CCATTTGCTTTTCCTTCTCCTTTTCTACCC	NULL
Pu	NULL
box	NULL
A19	NULL
-186	NULL
GGGTAGAAAAGGAGAAGGAAAAGCAAATGG	NULL
Pu	NULL
box	NULL
$	NULL
20	NULL
-125	NULL
ttATAATAAACCTGGGGGAAAGAGTGATAAAA	NULL
MAF	NULL
A20	NULL
-96	NULL
aaTTTTATCACTCTTTCCCCCAGGTTTATTAT	NULL
MAF	NULL
S2l	NULL
-854	NULL
aaCCATCCCGTGGGATGGAAAGTACAGACCCCATTAGAGTT	NULL
D	NULL
(	NULL
+	NULL
)	NULL
A21	NULL
-316	NULL
ttAACTCTAATGGGGTCTGTACTTTCCATCCCACGGGATGG	NULL
D	NULL
(	NULL
+	NULL
)	NULL
822	NULL
-825	NULL
CATTAGAGTTCTGACCAATCAAACCATGTA	NULL
D	NULL
(	NULL
-	NULL
)	NULL
A22	NULL
-296	NULL
TACATGGTTTGATTGGTCAGAACTCTAATG	NULL
D	NULL
(	NULL
-	NULL
)	NULL
SV40	NULL
S	NULL
AP3	NULL
-248	NULL
gatGTGTGGAAAGTCCCagtag	NULL
AP3	NULL
A	NULL
AP3	NULL
-233	NULL
ctactGGGACTTTCCACACate	NULL
AP3	NULL
CCP1	NULL
(	NULL
CTL	NULL
protease	NULL
)	NULL
S	NULL
C11	NULL
-156	NULL
aGeTTCTCTGAGTCATTCa	NULL
API	NULL
A	NULL
C11	NULL
-138	NULL
agcttGAATGACTCAGAGA	NULL
API	NULL
differences	NULL
compared	NULL
to	NULL
the	NULL
lower	NULL
strand	NULL
results	NULL
of	NULL
Fig	NULL
.	NULL

24	NULL
.	NULL

Specifically	NULL
,	NULL
the	NULL
-296	NULL
to	NULL
-323	NULL
region	NULL
was	NULL
protected	NULL
by	NULL
uninduced	NULL
nuclear	NULL
extracts	NULL
,	NULL
whereas	NULL
the	NULL
-325	NULL
to	NULL
-349	NULL
region	NULL
was	NULL
protected	NULL
with	NULL
induced	NULL
extracts	NULL
.	NULL

We	NULL
have	NULL
repeated	NULL
these	NULL
experiments	NULL
three	NULL
times	NULL
with	NULL
each	NULL
of	NULL
the	NULL
lower	NULL
and	NULL
upper	NULL
strands	NULL
,	NULL
using	NULL
either	NULL
PMA/ionomycin	NULL
or	NULL
PMA/A23187	NULL
as	NULL
inducing	NULL
agents	NULL
(	NULL
the	NULL
two	NULL
calcium	NULL
ionophores	NULL
are	NULL
similarly	NULL
effective	NULL
in	NULL
inducing	NULL
IL2	NULL
synthesis	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
showed	NULL
no	NULL
difference	NULL
in	NULL
footprinting	NULL
results	NULL
)	NULL
.	NULL

The	NULL
META	NULL
(	NULL
D	NULL
)	NULL
footprint	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
was	NULL
the	NULL
only	NULL
case	NULL
in	NULL
which	NULL
both	NULL
parts	NULL
of	NULL
META	NULL
(	NULL
D	NULL
)	NULL
were	NULL
protected	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
induced	NULL
cells	NULL
only	NULL
.	NULL

All	NULL
of	NULL
the	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
upper	NULL
strand	NULL
was	NULL
labeled	NULL
were	NULL
similar	NULL
to	NULL
the	NULL
result	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
.	NULL

Two	NULL
out	NULL
of	NULL
three	NULL
experiments	NULL
with	NULL
the	NULL
lower	NULL
strand	NULL
labeled	NULL
also	NULL
showed	NULL
this	NULL
protection	NULL
pat-tern	NULL
,	NULL
i.e	NULL
.	NULL

protection	NULL
of	NULL
one	NULL
element	NULL
of	NULL
META	NULL
(	NULL
D	NULL
)	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
)	NULL
,	NULL
and	NULL
of	NULL
an	NULL
adjacent	NULL
element	NULL
in	NULL
stimulated	NULL
cells	NULL
(	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
)	NULL
.	NULL

The	NULL
single	NULL
anomalous	NULL
result	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
i.e	NULL
.	NULL

protection	NULL
of	NULL
the	NULL
complete	NULL
META	NULL
(	NULL
D	NULL
)	NULL
region	NULL
by	NULL
induced	NULL
extracts	NULL
,	NULL
did	NULL
not	NULL
result	NULL
from	NULL
either	NULL
peculiarities	NULL
of	NULL
the	NULL
binding	NULL
reaction	NULL
or	NULL
limited	NULL
resolution	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
gel	NULL
;	NULL
the	NULL
results	NULL
were	NULL
reproducible	NULL
with	NULL
that	NULL
extract	NULL
and	NULL
were	NULL
unchanged	NULL
upon	NULL
longer	NULL
electrophoresis	NULL
.	NULL

In	NULL
all	NULL
experiments	NULL
,	NULL
however	NULL
,	NULL
META	NULL
(	NULL
D	NULL
)	NULL
and	NULL
META	NULL
(	NULL
P	NULL
)	NULL
always	NULL
exhibited	NULL
differential	NULL
protection	NULL
,	NULL
and	NULL
no	NULL
protected	NULL
regions	NULL
other	NULL
than	NULL
these	NULL
were	NULL
seen	NULL
in	NULL
the	NULL
411-bp	NULL
META	NULL
sequence	NULL
.	NULL

To	NULL
summarize	NULL
,	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
element	NULL
was	NULL
consistently	NULL
protected	NULL
by	NULL
extracts	NULL
from	NULL
induced	NULL
cells	NULL
,	NULL
relative	NULL
to	NULL
uninduced	NULL
extracts	NULL
.	NULL

In	NULL
most	NULL
cases	NULL
,	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
was	NULL
protected	NULL
by	NULL
extracts	NULL
from	NULL
uninduced	NULL
cells	NULL
(	NULL
the	NULL
exception	NULL
being	NULL
the	NULL
result	NULL
of	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

META	NULL
(	NULL
P	NULL
)	NULL
was	NULL
protected	NULL
weakly	NULL
by	NULL
extracts	NULL
of	NULL
induced	NULL
cells	NULL
.	NULL

META	NULL
(	NULL
D+	NULL
)	NULL
protection	NULL
was	NULL
the	NULL
most	NULL
strongly	NULL
correlated	NULL
with	NULL
conditions	NULL
of	NULL
transcriptional	NULL
induction	NULL
of	NULL
META	NULL
itself	NULL
(	NULL
9	NULL
)	NULL
and	NULL
of	NULL
lymphokines	NULL
,	NULL
and	NULL
it	NULL
was	NULL
therefore	NULL
selected	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

Binding	NULL
of	NULL
Jurkat	NULL
Nuclear	NULL
Factors	NULL
to	NULL
the	NULL
META	NULL
(	NULL
D	NULL
)	NULL
Ele-ments-The	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
and	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
elements	NULL
are	NULL
delin-	NULL
eated	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
these	NULL
sequences	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
were	NULL
used	NULL
to	NULL
look	NULL
for	NULL
binding	NULL
factors	NULL
by	NULL
gel	NULL
shift	NULL
analysis	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
D	NULL
(	NULL
+	NULL
)	NULL
probe	NULL
(	NULL
Zanes	NULL
1-4	NULL
)	NULL
demonstrated	NULL
one	NULL
very	NULL
strong	NULL
complex	NULL
(	NULL
arrow	NULL
1	NULL
)	NULL
,	NULL
and	NULL
one	NULL
that	NULL
was	NULL
barely	NULL
detectable	NULL
(	NULL
arrow	NULL
2	NULL
)	NULL
with	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
.	NULL

Under	NULL
conditions	NULL
of	NULL
transcriptional	NULL
activation	NULL
,	NULL
a	NULL
very	NULL
strong	NULL
additional	NULL
band	NULL
of	NULL
intermediate	NULL
mobility	NULL
(	NULL
arrow	NULL
3	NULL
)	NULL
was	NULL
seen	NULL
,	NULL
and	NULL
a	NULL
greatly	NULL
enhanced	NULL
amount	NULL
of	NULL
complex	NULL
in	NULL
the	NULL
region	NULL
of	NULL
the	NULL
slower	NULL
constitutive	NULL
band	NULL
(	NULL
arrow	NULL
2	NULL
)	NULL
.	NULL

Formation	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
almost	NULL
completely	NULL
abolished	NULL
by	NULL
CsA	NULL
,	NULL
which	NULL
blocks	NULL
activation	NULL
of	NULL
META	NULL
transcription	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

The	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
probe	NULL
(	NULL
Zanes	NULL
5-8	NULL
)	NULL
showed	NULL
a	NULL
strong	NULL
band	NULL
with	NULL
uninduced	NULL
cell	NULL
extracts	NULL
,	NULL
which	NULL
was	NULL
almost	NULL
completely	NULL
abolished	NULL
under	NULL
conditions	NULL
of	NULL
cellular	NULL
induction	NULL
,	NULL
and	NULL
was	NULL
partially	NULL
restored	NULL
when	NULL
CsA	NULL
was	NULL
present	NULL
(	NULL
arrow	NULL
4	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
gel	NULL
shift	NULL
analysis	NULL
are	NULL
consistent	NULL
overall	NULL
with	NULL
the	NULL
results	NULL
from	NULL
DNase	NULL
footprinting	NULL
,	NULL
in	NULL
that	NULL
a	NULL
specific	NULL
complex	NULL
was	NULL
found	NULL
under	NULL
conditions	NULL
of	NULL
transcriptional	NULL
activation	NULL
when	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
,	NULL
whereas	NULL
the	NULL
reciprocal	NULL
pattern	NULL
was	NULL
seen	NULL
with	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
as	NULL
probe	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
Inducible	NULL
Complex-The	NULL
binding	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
probe	NULL
was	NULL
investigated	NULL
by	NULL
using	NULL
unlabeled	NULL
homologous	NULL
and	NULL
heterologous	NULL
competing	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
signal	NULL
due	NULL
to	NULL
binding	NULL
of	NULL
both	NULL
constitutive	NULL
and	NULL
induction-dependent	NULL
factors	NULL
to	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
was	NULL
titrated	NULL
out	NULL
by	NULL
unlabeled	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
probe	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
nonspecific	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
a	NULL
nearby	NULL
,	NULL
but	NULL
unrelated	NULL
,	NULL
META	NULL
sequence	NULL
of	NULL
similar	NULL
length	NULL
.	NULL

(	NULL
The	NULL
nonspecific	NULL
competitor	NULL
contains	NULL
an	NULL
element	NULL
similar	NULL
to	NULL
the	NULL
AP3/TCEp	NULL
motif	NULL
of	NULL
the	NULL
upstream	NULL
control	NULL
region	NULL
of	NULL
IL2	NULL
(	NULL
13	NULL
)	NULL
)	NULL
.	NULL

The	NULL
41-bp	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
probe	NULL
contains	NULL
an	NULL
Rsal	NULL
site	NULL
between	NULL
positions	NULL
-334	NULL
and	NULL
-333	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

When	NULL
the	NULL
probe	NULL
was	NULL
treated	NULL
with	NULL
Rsal	NULL
,	NULL
no	NULL
retarded	NULL
band	NULL
was	NULL
seen	NULL
with	NULL
any	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
central	NULL
region	NULL
of	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
must	NULL
be	NULL
intact	NULL
for	NULL
binding	NULL
of	NULL
nuclear	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
8946	NULL
T	NULL
Cell-specific	NULL
Enhancer	NULL
in	NULL
MMTV	NULL
env	NULL
Gene	NULL
Probe	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
NE	NULL
P	NULL
-	NULL
+	NULL
CSA	NULL
2	NULL
--	NULL
f	NULL
3	NULL
-	NULL
»	NULL
{	NULL
-a	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
META	NULL
(	NULL
D	NULL
)	NULL
region	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
or	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
probes	NULL
at	NULL
0.5	NULL
nm	NULL
.	NULL

The	NULL
probe	NULL
for	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
consisted	NULL
of	NULL
oligonucleotides	NULL
S21	NULL
+	NULL
A21	NULL
,	NULL
and	NULL
the	NULL
probe	NULL
for	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
,	NULL
of	NULL
oligonucleotides	NULL
822	NULL
+	NULL
A22	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Lanes	NULL
1-4	NULL
,	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
probe	NULL
;	NULL
lanes	NULL
5-8	NULL
,	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
probe	NULL
.	NULL

NE	NULL
,	NULL
nuclear	NULL
extract	NULL
;	NULL
FP	NULL
,	NULL
free	NULL
probe	NULL
;	NULL
-	NULL
,	NULL
nuclear	NULL
extract	NULL
from	NULL
uninduced	NULL
Jurkat	NULL
cells	NULL
;	NULL
+	NULL
,	NULL
nuclear	NULL
extract	NULL
from	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
A23187	NULL
;	NULL
CsA	NULL
,	NULL
nuclear	NULL
extract	NULL
from	NULL
induced	NULL
plus	NULL
CsA-treated	NULL
cells	NULL
.	NULL

Arrow	NULL
3	NULL
on	NULL
the	NULL
left	NULL
points	NULL
to	NULL
the	NULL
complex	NULL
found	NULL
only	NULL
with	NULL
induced	NULL
extract	NULL
,	NULL
and	NULL
almost	NULL
completely	NULL
suppressed	NULL
by	NULL
CsA	NULL
.	NULL

Arrow	NULL
1	NULL
identifies	NULL
a	NULL
constitutive	NULL
complex	NULL
,	NULL
while	NULL
arrow	NULL
2	NULL
points	NULL
to	NULL
a	NULL
complex	NULL
barely	NULL
visible	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
and	NULL
strongly	NULL
induced	NULL
by	NULL
PMA	NULL
plus	NULL
A23187	NULL
.	NULL

The	NULL
complex	NULL
observed	NULL
with	NULL
the	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
probe	NULL
(	NULL
arrow	NULL
4	NULL
)	NULL
was	NULL
seen	NULL
with	NULL
uninduced	NULL
extracts	NULL
and	NULL
with	NULL
extracts	NULL
induced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
,	NULL
and	NULL
was	NULL
barely	NULL
visible	NULL
with	NULL
extracts	NULL
from	NULL
induced	NULL
cells	NULL
.	NULL

A	NULL
slower	NULL
migrating	NULL
complex	NULL
(	NULL
arrow	NULL
5	NULL
)	NULL
was	NULL
just	NULL
detectable	NULL
with	NULL
uninduced	NULL
and	NULL
CsA-treated	NULL
cell	NULL
extracts	NULL
.	NULL

factors	NULL
.	NULL

This	NULL
segment	NULL
contains	NULL
an	NULL
AP3/NF-	NULL
«	NULL
B	NULL
motif	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
and	NULL
``	NULL
Discussion	NULL
``	NULL
)	NULL
.	NULL

The	NULL
induced	NULL
and	NULL
constitutive	NULL
complexes	NULL
of	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
differed	NULL
in	NULL
sensitivity	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
unlabeled	NULL
homologous	NULL
probe	NULL
,	NULL
with	NULL
the	NULL
induced	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
arrow	NULL
)	NULL
showing	NULL
a	NULL
greater	NULL
sensitivity	NULL
,	NULL
possibly	NULL
reflecting	NULL
a	NULL
lower	NULL
concentration	NULL
of	NULL
the	NULL
factor	NULL
responsible	NULL
.	NULL

The	NULL
results	NULL
of	NULL
competition	NULL
show	NULL
that	NULL
the	NULL
binding	NULL
was	NULL
specific	NULL
and	NULL
saturable	NULL
.	NULL

The	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
Sequence	NULL
Confers	NULL
Inducible	NULL
,	NULL
CSA-suppress-ible	NULL
,	NULL
Transcriptional	NULL
Activation-To	NULL
determine	NULL
the	NULL
enhancer	NULL
function	NULL
of	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
in	NULL
intact	NULL
cells	NULL
,	NULL
we	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
with	NULL
plasmids	NULL
containing	NULL
various	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
-related	NULL
con-structs	NULL
,	NULL
driving	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
the	NULL
enhancer	NULL
constructs	NULL
were	NULL
compared	NULL
to	NULL
the	NULL
relevant	NULL
promoter	NULL
constructs	NULL
lacking	NULL
enhancers	NULL
.	NULL

The	NULL
pGL-2	NULL
plasmid	NULL
containing	NULL
an	NULL
SV40	NULL
promoter/enhancer	NULL
sequence	NULL
,	NULL
included	NULL
as	NULL
a	NULL
control	NULL
,	NULL
showed	NULL
increased	NULL
luciferase	NULL
gene	NULL
expression	NULL
on	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
A23187	NULL
,	NULL
as	NULL
has	NULL
been	NULL
observed	NULL
by	NULL
others	NULL
(	NULL
13	NULL
,	NULL
24	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
observed	NULL
with	NULL
the	NULL
full-length	NULL
411-bp	NULL
META	NULL
region	NULL
(	NULL
pDSM25F	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
was	NULL
also	NULL
stimulated	NULL
by	NULL
activation	NULL
with	NULL
PMA	NULL
and	NULL
calcium	NULL
ionophore	NULL
,	NULL
and	NULL
this	NULL
activity	NULL
was	NULL
CsA-sensitive	NULL
.	NULL

This	NULL
is	NULL
parallel	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
META	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
reporter	NULL
(	NULL
9	NULL
)	NULL
.	NULL

When	NULL
individual	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
enhancer	NULL
elements	NULL
were	NULL
linked	NULL
to	NULL
the	NULL
tk	NULL
promoter	NULL
,	NULL
luciferase	NULL
expression	NULL
was	NULL
also	NULL
induced	NULL
by	NULL
PMA	NULL
plus	NULL
A23187	NULL
,	NULL
with	NULL
the	NULL
strength	NULL
of	NULL
induction	NULL
being	NULL
related	NULL
to	NULL
the	NULL
number	NULL
of	NULL
elements	NULL
placed	NULL
in	NULL
series	NULL
.	NULL

Activation	NULL
did	NULL
not	NULL
require	NULL
the	NULL
elements	NULL
to	NULL
be	NULL
oriented	NULL
in	NULL
one	NULL
direction	NULL
,	NULL
and	NULL
in	NULL
every	NULL
case	NULL
was	NULL
strongly	NULL
sensitive	NULL
to	NULL
CsA	NULL
.	NULL

A	NULL
7-mer	NULL
of	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
generated	NULL
more	NULL
than	NULL
a	NULL
100-fold	NULL
induction	NULL
upon	NULL
activation	NULL
,	NULL
compared	NULL
to	NULL
the	NULL
enhancerless	NULL
promoter	NULL
construct	NULL
,	NULL
with	NULL
93	NULL
%	NULL
of	NULL
the	NULL
induced	NULL
activity	NULL
being	NULL
inhibited	NULL
by	NULL
CsA	NULL
.	NULL

The	NULL
tandem	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
arrays	NULL
were	NULL
not	NULL
only	NULL
induced	NULL
rela-	NULL
Probe	NULL
Competing	NULL
Oligo	NULL
Amount	NULL
(	NULL
X	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
86	NULL
7	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Specificity	NULL
and	NULL
saturability	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
binding	NULL
site	NULL
.	NULL

A	NULL
gel	NULL
shift	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
using	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

Lanes	NULL
3-5	NULL
show	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
induction-dependent	NULL
nuclear	NULL
factor	NULL
(	NULL
arrow	NULL
)	NULL
could	NULL
be	NULL
titrated	NULL
away	NULL
with	NULL
the	NULL
unlabeled	NULL
``	NULL
self	NULL
``	NULL
probe	NULL
due	NULL
to	NULL
saturation	NULL
.	NULL

An	NULL
unrelated	NULL
oligonucleo-tide	NULL
,	NULL
corresponding	NULL
to	NULL
positions	NULL
-278	NULL
to	NULL
-253	NULL
of	NULL
META	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
did	NULL
not	NULL
compete	NULL
(	NULL
NS	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Amount	NULL
(	NULL
x	NULL
)	NULL
indicates	NULL
the	NULL
molar	NULL
ratio	NULL
of	NULL
unlabeled	NULL
competitors	NULL
to	NULL
labeled	NULL
probe	NULL
.	NULL

tively	NULL
more	NULL
by	NULL
activation	NULL
than	NULL
was	NULL
the	NULL
pGL-2	NULL
SV40	NULL
construct	NULL
,	NULL
under	NULL
induced	NULL
conditions	NULL
they	NULL
were	NULL
higher	NULL
in	NULL
absolute	NULL
level	NULL
as	NULL
well	NULL
,	NULL
with	NULL
the	NULL
most	NULL
powerful	NULL
,	NULL
pDSD	NULL
65	NULL
,	NULL
being	NULL
almost	NULL
100	NULL
times	NULL
as	NULL
strongly	NULL
expressed	NULL
as	NULL
the	NULL
SV40	NULL
enhancer-promoter	NULL
combination	NULL
(	NULL
numerical	NULL
data	NULL
are	NULL
given	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Full	NULL
Activation	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
Enhancer	NULL
Requires	NULL
Both	NULL
PMA	NULL
and	NULL
Calcium	NULL
Ionophore	NULL
and	NULL
Is	NULL
T	NULL
Cell-specific-In	NULL
an	NULL
earlier	NULL
study	NULL
we	NULL
showed	NULL
that	NULL
the	NULL
411-bp	NULL
META	NULL
fragment	NULL
mediates	NULL
T	NULL
cell-specific	NULL
,	NULL
induction-dependent	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
that	NULL
study	NULL
,	NULL
META	NULL
was	NULL
activated	NULL
in	NULL
both	NULL
mouse	NULL
(	NULL
EL4.E1	NULL
)	NULL
and	NULL
human	NULL
(	NULL
Jurkat	NULL
)	NULL
T	NULL
helper	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
in	NULL
a	NULL
mouse	NULL
T	NULL
helper	NULL
hybridoma	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
dual	NULL
signal	NULL
requirement	NULL
and	NULL
T	NULL
cell	NULL
specificity	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
enhancer	NULL
element	NULL
was	NULL
therefore	NULL
investigated	NULL
using	NULL
several	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
Jurkat	NULL
transfected	NULL
with	NULL
plasmid	NULL
pDSD	NULL
65	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
to	NULL
calcium	NULL
ionophore	NULL
alone	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
reporter	NULL
construct	NULL
.	NULL

Stimulation	NULL
with	NULL
PMA	NULL
alone	NULL
increased	NULL
the	NULL
activity	NULL
to	NULL
about	NULL
37	NULL
%	NULL
of	NULL
the	NULL
maximum	NULL
activity	NULL
generated	NULL
with	NULL
both	NULL
PMA	NULL
and	NULL
A23187	NULL
.	NULL

CsA	NULL
inhibited	NULL
87	NULL
%	NULL
of	NULL
the	NULL
fully	NULL
induced	NULL
activity	NULL
,	NULL
whereas	NULL
PMA-induced	NULL
activity	NULL
was	NULL
only	NULL
inhibited	NULL
by	NULL
33	NULL
%	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
enhancer	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
type	NULL
of	NULL
cell	NULL
used	NULL
for	NULL
transfection	NULL
.	NULL

The	NULL
T	NULL
lymphocyte	NULL
cell	NULL
lines	NULL
EL4.E1	NULL
and	NULL
Jurkat	NULL
showed	NULL
high	NULL
levels	NULL
of	NULL
inducible	NULL
activity	NULL
compared	NULL
to	NULL
the	NULL
non-T	NULL
cells	NULL
8194	NULL
and	NULL
Hela	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
both	NULL
$	NULL
194	NULL
and	NULL
Hela	NULL
cells	NULL
contain	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP3	NULL
factors	NULL
under	NULL
constitutive	NULL
and/or	NULL
inducing	NULL
conditions	NULL
,	NULL
yet	NULL
did	NULL
not	NULL
significantly	NULL
activate	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D	NULL
)	NULL
Sequence	NULL
to	NULL
Various	NULL
Cellular	NULL
and	NULL
Viral	NULL
Enhancers-Examination	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D	NULL
)	NULL
region	NULL
revealed	NULL
several	NULL
potential	NULL
motifs	NULL
for	NULL
binding	NULL
transcription	NULL
factors	NULL
API	NULL
,	NULL
AP2	NULL
,	NULL
AP3	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
AP3	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
SV40	NULL
enhancer	NULL
mediates	NULL
tissue-specific	NULL
,	NULL
inducible	NULL
enhancer	NULL
functions	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
.	NULL

Several	NULL
factors	NULL
interact	NULL
with	NULL
SV40	NULL
core	NULL
sequence	NULL
,	NULL
including	NULL
a	NULL
family	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
related	NULL
proteins	NULL
(	NULL
p50	NULL
,	NULL
p55	NULL
,	NULL
p65	NULL
,	NULL
p75	NULL
,	NULL
p85	NULL
)	NULL
from	NULL
stimu-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
T	NULL
Cell-specific	NULL
Enhancer	NULL
in	NULL
MMTV	NULL
env	NULL
Gene	NULL
8947	NULL
Plasmid	NULL
0	NULL
paL-2	NULL
[	NULL
Z27|	NULL
5730	NULL
prm	NULL
|	NULL
-	NULL
439	NULL
-29	NULL
popsy	NULL
25F	NULL
-	NULL
|___	NULL
[	NULL
»	NULL
]	NULL
|	NULL
pDsD	NULL
63	NULL
pm	NULL
]	NULL
pDSD	NULL
69	NULL
pDSD	NULL
61	NULL
__	NULL
[	NULL
Luc	NULL
]	NULL
posD	NULL
65	NULL
Rel	NULL
.	NULL

Fold	NULL
Induction	NULL
25	NULL
50	NULL
75	NULL
100	NULL
125	NULL
I	NULL
1	NULL
I	NULL
pGL-2	NULL
pGL-2	NULL
pDS-tk13	NULL
|	NULL
pDSM25F	NULL
pDSD63	NULL
pDSD69	NULL
pDSDé1	NULL
pDSD65	NULL
(	NULL
enh-	NULL
)	NULL
(	NULL
enh-	NULL
)	NULL
uninduced	NULL
73	NULL
78	NULL
330	NULL
520	NULL
290	NULL
320	NULL
21	NULL
370	NULL
induced	NULL
860	NULL
5,510	NULL
3,370	NULL
18,080	NULL
20,150	NULL
34,060	NULL
9,800	NULL
393,200	NULL
induced	NULL
-	NULL
-	NULL
566	NULL
(	NULL
17	NULL
)	NULL
680	NULL
(	NULL
.04	NULL
)	NULL
1140	NULL
(	NULL
.06	NULL
)	NULL
1620	NULL
(	NULL
05	NULL
)	NULL
310	NULL
(	NULL
03	NULL
)	NULL
|	NULL
27,400	NULL
{	NULL
.07	NULL
)	NULL
+CsA	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Inducible	NULL
and	NULL
CsA-suppressible	NULL
expression	NULL
of	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
-luciferase	NULL
constructs	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
structures	NULL
of	NULL
the	NULL
plasmids	NULL
used	NULL
are	NULL
schematically	NULL
shown	NULL
to	NULL
the	NULL
Zeft	NULL
of	NULL
the	NULL
graph	NULL
that	NULL
depicts	NULL
their	NULL
induction	NULL
by	NULL
PMA	NULL
plus	NULL
A23187	NULL
.	NULL

Plasmid	NULL
pGL-2	NULL
control	NULL
vector	NULL
contained	NULL
an	NULL
SV40	NULL
promoter	NULL
and	NULL
enhancer	NULL
.	NULL

All	NULL
other	NULL
plasmids	NULL
were	NULL
expressed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
(	NULL
¥	NULL
prm	NULL
)	NULL
.	NULL

The	NULL
compositions	NULL
of	NULL
the	NULL
plasmids	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
pDSM25F	NULL
,	NULL
complete	NULL
META	NULL
region	NULL
,	NULL
containing	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
;	NULL
pDSD	NULL
63	NULL
,	NULL
pDSD	NULL
69	NULL
,	NULL
pDSD	NULL
61	NULL
,	NULL
pDSD	NULL
65	NULL
,	NULL
plasmids	NULL
containing	NULL
the	NULL
39-bp	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
element	NULL
in	NULL
3-7	NULL
copies	NULL
upstream	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
,	NULL
in	NULL
the	NULL
orientations	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Rel	NULL
.	NULL

fold	NULL
.	NULL

induction	NULL
represents	NULL
the	NULL
induced/uninduced	NULL
signals	NULL
for	NULL
a	NULL
given	NULL
construct	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
same	NULL
ratio	NULL
for	NULL
the	NULL
appropriate	NULL
enhancerless	NULL
promoter	NULL
.	NULL

The	NULL
actual	NULL
values	NULL
of	NULL
the	NULL
luciferase	NULL
assay	NULL
are	NULL
given	NULL
in	NULL
the	NULL
table	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
(	NULL
light	NULL
units/10	NULL
ug	NULL
of	NULL
protein	NULL
in	NULL
the	NULL
assay	NULL
)	NULL
.	NULL

pGL-2	NULL
and	NULL
pDS-tk18	NULL
are	NULL
the	NULL
enhancerless	NULL
promoters	NULL
of	NULL
SV40	NULL
and	NULL
thymidine	NULL
kinase	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
luciferase	NULL
expression	NULL
values	NULL
for	NULL
the	NULL
plasmids	NULL
induced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
are	NULL
also	NULL
given	NULL
in	NULL
the	NULL
table	NULL
(	NULL
bottom	NULL
row	NULL
)	NULL
,	NULL
with	NULL
the	NULL
expression	NULL
in	NULL
CsA	NULL
relative	NULL
to	NULL
the	NULL
maximum	NULL
in	NULL
parentheses	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
from	NULL
a	NULL
single	NULL
transfection	NULL
experiment	NULL
,	NULL
but	NULL
similar	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

lated	NULL
Jurkat	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
,	NULL
TCF-1	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-3	NULL
from	NULL
EL4	NULL
cells	NULL
(	NULL
31	NULL
)	NULL
,	NULL
NP-TCII	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
,	NULL
AP3	NULL
from	NULL
Hela	NULL
cells	NULL
,	NULL
and	NULL
authentic	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
B-lymphocytes	NULL
(	NULL
25	NULL
,	NULL
33	NULL
)	NULL
.	NULL

These	NULL
classes	NULL
of	NULL
proteins	NULL
also	NULL
bind	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sequence	NULL
in	NULL
the	NULL
human	NULL
IL2	NULL
enhancer	NULL
(	NULL
13	NULL
,	NULL
18	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
sequence	NULL
shows	NULL
similarity	NULL
to	NULL
AP3	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

Except	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
element	NULL
of	NULL
the	NULL
IL2	NULL
enhancer	NULL
(	NULL
tGAAA	NULL
)	NULL
,	NULL
all	NULL
others	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
have	NULL
the	NULL
conserved	NULL
motif	NULL
GGAAA	NULL
characteristic	NULL
of	NULL
the	NULL
binding	NULL
regions	NULL
for	NULL
AP3	NULL
,	NULL
NF-kB	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Dorsal/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
NP-TC	NULL
II	NULL
motif	NULL
in	NULL
the	NULL
SV40	NULL
enhancer	NULL
resembles	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
,	NULL
but	NULL
it	NULL
binds	NULL
a	NULL
different	NULL
factor	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Enhancers	NULL
from	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
,	NULL
SV40	NULL
,	NULL
and	NULL
IL2	NULL
have	NULL
7-8	NULL
nucleotide	NULL
matches	NULL
to	NULL
the	NULL
consensus	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
GGGA	NULL
(	NULL
A/C	NULL
)	NULL
TN	NULL
(	NULL
T/C	NULL
)	NULL
CC	NULL
)	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
core	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IL2	NULL
enhancer	NULL
exhibits	NULL
6/10	NULL
matches	NULL
to	NULL
the	NULL
consensus	NULL
AP3	NULL
binding	NULL
sequence	NULL
(	NULL
TGTGG	NULL
{	NULL
(	NULL
A/T	NULL
)	NULL
(	NULL
A/T	NULL
)	NULL
(	NULL
A/T	NULL
)	NULL
GT	NULL
)	NULL
(	NULL
11	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
used	NULL
IL2	NULL
enhancer	NULL
DNA	NULL
or	NULL
specific	NULL
oligonucleotides	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
element	NULL
to	NULL
its	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
in	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
SV40	NULL
Oligonucleotide	NULL
Competes	NULL
for	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
Binding	NULL
Factor	NULL
,	NULL
but	NULL
NF-kB	NULL
Does	NULL
Not-We	NULL
investigated	NULL
the	NULL
binding	NULL
of	NULL
factors	NULL
in	NULL
activated	NULL
Jurkat	NULL
nuclei	NULL
to	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
competing	NULL
SV40	NULL
promoter	NULL
sequences	NULL
and	NULL
hIL2	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotides	NULL
.	NULL

SV40	NULL
contains	NULL
an	NULL
AP3	NULL
motif	NULL
(	NULL
33	NULL
)	NULL
,	NULL
and	NULL
also	NULL
an	NULL
element	NULL
that	NULL
binds	NULL
both	NULL
the	NULL
inducible	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
34	NULL
)	NULL
and	NULL
factor	NULL
NF-TCII	NULL
(	NULL
32	NULL
)	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
constitutively	NULL
in	NULL
T	NULL
and	NULL
B	NULL
lymphocyte	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
mobility	NULL
shift	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
demonstrate	NULL
that	NULL
the	NULL
22-bp	NULL
SV40	NULL
oligonucleotide	NULL
(	NULL
Zanes	NULL
3-6	NULL
)	NULL
competed	NULL
quite	NULL
efficiently	NULL
for	NULL
the	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
,	NULL
comparable	NULL
to	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
self-competition	NULL
(	NULL
cf	NULL
.	NULL

lane	NULL
4	NULL
of	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
hIL2	NULL
NF-	NULL
«	NULL
B	NULL
element	NULL
,	NULL
which	NULL
shows	NULL
only	NULL
a	NULL
limited	NULL
similarity	NULL
to	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
was	NULL
a	NULL
poor	NULL
competitor	NULL
;	NULL
even	NULL
a	NULL
200-fold	NULL
molar	NULL
excess	NULL
produced	NULL
only	NULL
a	NULL
modest	NULL
diminution	NULL
of	NULL
the	NULL
signal	NULL
(	NULL
Zanes	NULL
7-11	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
mammary	NULL
cell	NULL
activating	NULL
factor-like	NULL
region	NULL
of	NULL
META	NULL
(	NULL
-126	NULL
to	NULL
-96	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
and	NULL
which	NULL
also	NULL
contains	NULL
the	NULL
central	NULL
GGAAA	NULL
pentanucleotide	NULL
characteristic	NULL
of	NULL
the	NULL
AP3	NULL
or	NULL
NFAT	NULL
sites	NULL
,	NULL
did	NULL
not	NULL
compete	NULL
(	NULL
Zanes	NULL
12-14	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
sequences	NULL
flanking	NULL
the	NULL
pentanucleotide	NULL
are	NULL
essential	NULL
for	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
binding	NULL
.	NULL

The	NULL
competition	NULL
by	NULL
SV40	NULL
for	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
-binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
reciprocal	NULL
situation	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

The	NULL
SV40	NULL
probe	NULL
exhibited	NULL
a	NULL
mobility	NULL
shift	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
control	NULL
and	NULL
induced	NULL
Jurkat	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
two	NULL
patterns	NULL
were	NULL
completely	NULL
different	NULL
.	NULL

Nuclear	NULL
factors	NULL
from	NULL
uninduced	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
yielded	NULL
one	NULL
very	NULL
weak	NULL
band	NULL
of	NULL
fairly	NULL
high	NULL
mobility	NULL
,	NULL
whereas	NULL
induced	NULL
extracts	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
yielded	NULL
two	NULL
different	NULL
bands	NULL
,	NULL
much	NULL
stronger	NULL
and	NULL
of	NULL
lower	NULL
mobility	NULL
.	NULL

The	NULL
two	NULL
activation-dependent	NULL
bands	NULL
were	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
CsA	NULL
.	NULL

META	NULL
(	NULL
D+	NULL
)	NULL
did	NULL
not	NULL
compete	NULL
effectively	NULL
for	NULL
the	NULL
induced	NULL
com-plexes	NULL
,	NULL
compared	NULL
to	NULL
the	NULL
SV40	NULL
sequence	NULL
itself	NULL
.	NULL

The	NULL
human	NULL
IL2-derived	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
competed	NULL
moderately	NULL
well	NULL
for	NULL
the	NULL
lower	NULL
mobility	NULL
SV40	NULL
activation-dependent	NULL
complex	NULL
,	NULL
but	NULL
not	NULL
for	NULL
the	NULL
other	NULL
one	NULL
.	NULL

Search	NULL
for	NULL
a	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
Competitor	NULL
Sequence	NULL
in	NULL
the	NULL
IL2	NULL
Gene-One	NULL
of	NULL
the	NULL
interesting	NULL
features	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
complex	NULL
is	NULL
that	NULL
its	NULL
induction	NULL
is	NULL
abolished	NULL
by	NULL
the	NULL
immunosuppres-sive	NULL
drug	NULL
CsA	NULL
.	NULL

This	NULL
is	NULL
characteristic	NULL
of	NULL
very	NULL
few	NULL
transcriptional	NULL
activating	NULL
elements	NULL
,	NULL
chief	NULL
among	NULL
these	NULL
being	NULL
the	NULL
NFAT	NULL
element	NULL
of	NULL
the	NULL
IL2	NULL
and	NULL
other	NULL
cytokine	NULL
genes	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Although	NULL
NFAT	NULL
and	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
elements	NULL
both	NULL
contain	NULL
a	NULL
central	NULL
GGAAA	NULL
pen-tanucleotide	NULL
,	NULL
there	NULL
is	NULL
no	NULL
overall	NULL
similarity	NULL
between	NULL
them	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
because	NULL
of	NULL
their	NULL
functional	NULL
similarity	NULL
,	NULL
we	NULL
tested	NULL
human	NULL
IL2	NULL
upstream	NULL
DNA	NULL
probes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
an	NULL
oligonucleotide	NULL
carrying	NULL
the	NULL
NFAT	NULL
motif	NULL
,	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
compete	NULL
with	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
.	NULL

DNA	NULL
from	NULL
the	NULL
human	NULL
IL2	NULL
gene	NULL
representing	NULL
the	NULL
regions	NULL
+45	NULL
to	NULL
-183	NULL
,	NULL
-98	NULL
to	NULL
-362	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
AP1	NULL
and	NULL
NFAT	NULL
oligonucleotides	NULL
were	NULL
tested	NULL
as	NULL
competitors	NULL
individually	NULL
.	NULL

The	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
various	NULL
regions	NULL
in	NULL
META	NULL
,	NULL
namely	NULL
AP3/TCEp	NULL
,	NULL
polypurine	NULL
element	NULL
,	NULL
and	NULL
mammary	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
8948	NULL
cell	NULL
activating	NULL
factor	NULL
,	NULL
which	NULL
harbor	NULL
the	NULL
GG	NULL
{	NULL
(	NULL
A/T	NULL
)	NULL
(	NULL
A/T	NULL
)	NULL
(	NULL
A/T	NULL
)	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

1c	NULL
)	NULL
were	NULL
also	NULL
end-labeled	NULL
and	NULL
tested	NULL
individually	NULL
in	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

However	NULL
,	NULL
the	NULL
induction-dependent	NULL
binding	NULL
to	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
any	NULL
of	NULL
the	NULL
IL2	NULL
enhancer	NULL
elements	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
overall	NULL
conclusion	NULL
is	NULL
that	NULL
there	NULL
is	NULL
a	NULL
major	NULL
binding	NULL
site	NULL
for	NULL
inducible	NULL
,	NULL
CsA-suppressible	NULL
nuclear	NULL
factors	NULL
in	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
region	NULL
,	NULL
and	NULL
that	NULL
it	NULL
is	NULL
activated	NULL
in	NULL
parallel	NULL
with	NULL
,	NULL
but	NULL
distinct	NULL
from	NULL
,	NULL
the	NULL
IL2	NULL
NFAT	NULL
site	NULL
.	NULL

Rel	NULL
.	NULL

Fold	NULL
Induction	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
L_L	NULL
___	NULL
___	NULL
upp	NULL
j	NULL
ul	NULL
A	NULL
B	NULL
+CSA	NULL
Azsi87	NULL
-	NULL
m	NULL
-	NULL
CSA	NULL
PMA	NULL
PMA+A23187	NULL
Rel	NULL
.	NULL

Fold	NULL
Induction	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
sig4	NULL
7	NULL
B	NULL
Hela	NULL
a	NULL
EL4	NULL
Jurkat	NULL
|	NULL
-£3	NULL
%	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Dual	NULL
signal	NULL
requirement	NULL
and	NULL
T	NULL
lymphocyte	NULL
specificity	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
enhancer	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
luciferase	NULL
expression	NULL
plasmids	NULL
pDS-tk	NULL
18	NULL
or	NULL
pDSD65	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
and	NULL
stimulated	NULL
with	NULL
the	NULL
agents	NULL
shown	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
fold	NULL
induction	NULL
,	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

The	NULL
luciferase	NULL
activities	NULL
(	NULL
light	NULL
units/10	NULL
pug	NULL
)	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
uninduced	NULL
(	NULL
UZ	NULL
)	NULL
,	NULL
271	NULL
;	NULL
A23187	NULL
alone	NULL
,	NULL
404	NULL
;	NULL
PMA	NULL
alone	NULL
,	NULL
5,520	NULL
;	NULL
PMA	NULL
+	NULL
A23187	NULL
,	NULL
79,520	NULL
;	NULL
PMA	NULL
+	NULL
A23187	NULL
+	NULL
CSA	NULL
,	NULL
10,280	NULL
.	NULL

The	NULL
luciferase	NULL
activities	NULL
for	NULL
the	NULL
control	NULL
enhancerless	NULL
plasmid	NULL
pDS-tk	NULL
18	NULL
was	NULL
1,870/334	NULL
{	NULL
induced/uninduced	NULL
)	NULL
.	NULL

B	NULL
,	NULL
relative	NULL
activities	NULL
of	NULL
pDSD65	NULL
in	NULL
different	NULL
types	NULL
of	NULL
cells	NULL
.	NULL

8194	NULL
(	NULL
B	NULL
cell	NULL
)	NULL
,	NULL
Hela	NULL
(	NULL
fibroblast	NULL
)	NULL
,	NULL
EL4.E1	NULL
(	NULL
mouse	NULL
T	NULL
lymphoma	NULL
)	NULL
,	NULL
and	NULL
Jurkat	NULL
(	NULL
human	NULL
T	NULL
lymphocyte	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
plasmid	NULL
and	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
A23187	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
fold	NULL
induction	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
luciferase	NULL
activities	NULL
(	NULL
induced/	NULL
uninduced	NULL
)	NULL
were	NULL
:	NULL
8194	NULL
,	NULL
189/77	NULL
;	NULL
HeLa	NULL
,	NULL
11,560/2,300	NULL
;	NULL
EL4.E1	NULL
,	NULL
459,600/	NULL
12,930	NULL
;	NULL
Jurkat	NULL
,	NULL
111,070/460	NULL
.	NULL

The	NULL
luciferase	NULL
activities	NULL
for	NULL
enhancerless	NULL
plasmid	NULL
pDS-tk	NULL
13	NULL
in	NULL
induced/uninduced	NULL
conditions	NULL
were	NULL
:	NULL
S194	NULL
,	NULL
194/90	NULL
;	NULL
HeLa	NULL
,	NULL
4,070/3,390	NULL
;	NULL
EL4.E1	NULL
,	NULL
26,790/14,890	NULL
;	NULL
Jurkat	NULL
,	NULL
3,220/431	NULL
.	NULL

Data	NULL
in	NULL
A	NULL
and	NULL
B	NULL
represent	NULL
the	NULL
results	NULL
from	NULL
different	NULL
experiments	NULL
.	NULL

These	NULL
profiles	NULL
were	NULL
reproduced	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

T	NULL
Cell-specific	NULL
Enhancer	NULL
in	NULL
MMTV	NULL
env	NULL
Gene	NULL
DISCUSSION	NULL
We	NULL
have	NULL
identified	NULL
an	NULL
enhancer	NULL
element	NULL
in	NULL
the	NULL
MMTV	NULL
env	NULL
gene	NULL
,	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
,	NULL
located	NULL
between	NULL
positions	NULL
-325	NULL
to	NULL
-350	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
site	NULL
of	NULL
the	NULL
transcript	NULL
of	NULL
the	NULL
3	NULL
'	NULL
LTR	NULL
described	NULL
earlier	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
the	NULL
META	NULL
fragment	NULL
extending	NULL
from	NULL
-431	NULL
to	NULL
-34	NULL
was	NULL
shown	NULL
to	NULL
confer	NULL
orientation-inde-pendent	NULL
,	NULL
induction-dependent	NULL
,	NULL
and	NULL
CsA-suppressible	NULL
activity	NULL
in	NULL
T	NULL
helper	NULL
lymphocytes	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
existence	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
element	NULL
was	NULL
suggested	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
and	NULL
confirmed	NULL
by	NULL
gel	NULL
retardation	NULL
assays	NULL
and	NULL
transient	NULL
transfection	NULL
studies	NULL
.	NULL

Multimers	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
element	NULL
conferred	NULL
activation-dependent	NULL
,	NULL
T	NULL
lymphocyte-specific	NULL
,	NULL
and	NULL
CsA-suppressible	NULL
expression	NULL
on	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
in	NULL
transient	NULL
transfections	NULL
.	NULL

The	NULL
overall	NULL
enhancer	NULL
strength	NULL
was	NULL
related	NULL
to	NULL
the	NULL
number	NULL
of	NULL
copies	NULL
of	NULL
the	NULL
element	NULL
,	NULL
but	NULL
did	NULL
not	NULL
require	NULL
that	NULL
the	NULL
individual	NULL
copies	NULL
be	NULL
oriented	NULL
in	NULL
the	NULL
same	NULL
direction	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Two	NULL
other	NULL
putative	NULL
control	NULL
elements	NULL
,	NULL
META	NULL
(	NULL
P	NULL
)	NULL
and	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
,	NULL
were	NULL
indicated	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
.	NULL

Data	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
suggest	NULL
that	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
may	NULL
be	NULL
a	NULL
negative	NULL
control	NULL
region	NULL
,	NULL
since	NULL
in	NULL
almost	NULL
every	NULL
experiment	NULL
a	NULL
binding	NULL
complex	NULL
was	NULL
found	NULL
under	NULL
non-transcribing	NULL
conditions	NULL
only	NULL
(	NULL
either	NULL
uninduced	NULL
cells	NULL
,	NULL
or	NULL
cells	NULL
induced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
several	NULL
DNase	NULL
I	NULL
footprinting	NULL
reactions	NULL
carried	NULL
out	NULL
,	NULL
there	NULL
was	NULL
only	NULL
one	NULL
instance	NULL
where	NULL
the	NULL
protection	NULL
with	NULL
induced	NULL
nuclear	NULL
extracts	NULL
occurred	NULL
over	NULL
the	NULL
entire	NULL
META	NULL
(	NULL
D	NULL
)	NULL
region	NULL
(	NULL
this	NULL
exception	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
mobility	NULL
shift	NULL
experiments	NULL
with	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
its	NULL
being	NULL
a	NULL
negative	NULL
element	NULL
(	NULL
i.e	NULL
.	NULL

complexes	NULL
were	NULL
formed	NULL
under	NULL
non-transcribing	NULL
conditions	NULL
only	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D-	NULL
)	NULL
sequence	NULL
indicated	NULL
a	NULL
potential	NULL
AP1	NULL
binding	NULL
site	NULL
,	NULL
TGACcAA	NULL
,	NULL
in	NULL
the	NULL
-314	NULL
to	NULL
-308	NULL
region	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
closely	NULL
spaced	NULL
(	NULL
D+	NULL
)	NULL
and	NULL
D	NULL
(	NULL
-	NULL
)	NULL
elements	NULL
in	NULL
META	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
-208	NULL
to	NULL
-188	NULL
)	NULL
and	NULL
AP1	NULL
(	NULL
-185	NULL
to	NULL
-178	NULL
)	NULL
elements	NULL
in	NULL
the	NULL
IL2	NULL
enhancer	NULL
are	NULL
also	NULL
adjacent	NULL
.	NULL

Footprinting	NULL
analysis	NULL
of	NULL
the	NULL
IL2	NULL
enhancer	NULL
in	NULL
vivo	NULL
has	NULL
revealed	NULL
that	NULL
the	NULL
AP1	NULL
element	NULL
is	NULL
protected	NULL
under	NULL
uninduced	NULL
conditions	NULL
,	NULL
whereas	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
element	NULL
is	NULL
protected	NULL
under	NULL
conditions	NULL
of	NULL
induction	NULL
(	NULL
19	NULL
)	NULL
.	NULL

A	NULL
negative	NULL
role	NULL
for	NULL
the	NULL
distal	NULL
AP1	NULL
site	NULL
in	NULL
mouse	NULL
IL2	NULL
upstream	NULL
sequence	NULL
has	NULL
been	NULL
suggested	NULL
,	NULL
since	NULL
it	NULL
showed	NULL
diminished	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
from	NULL
stimulated	NULL
cells	NULL
compared	NULL
to	NULL
the	NULL
unstimulated	NULL
ones	NULL
(	NULL
35	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
strong	NULL
and	NULL
reproducible	NULL
footprints	NULL
found	NULL
for	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
,	NULL
the	NULL
proximal	NULL
site	NULL
at	NULL
META	NULL
(	NULL
P	NULL
)	NULL
was	NULL
only	NULL
weakly	NULL
protected	NULL
,	NULL
and	NULL
we	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
it	NULL
has	NULL
an	NULL
enhancer	NULL
function	NULL
.	NULL

META	NULL
(	NULL
D+	NULL
)	NULL
contains	NULL
an	NULL
inverted	NULL
repeat	NULL
overlapping	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
central	NULL
binding	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Such	NULL
structures	NULL
can	NULL
«	NULL
<	NULL
G	NULL
FOOTPRINT	NULL
_	NULL
»	NULL
PALINDROME	NULL
fy	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
aaCCATCCCGTGGGATGGAAAGTACAGACCCClATTAGAGTT	NULL
|	NULL
_	NULL
(	NULL
ap2	NULL
78	NULL
)	NULL
||	NULL
(	NULL
aps	NULL
83/710	NULL
)	NULL
I	NULL
(	NULL
NF-KB	NULL
8/10	NULL
)	NULL
i	NULL
(	NULL
NF-KB	NULL
7/10	NULL
)	NULL
SV40	NULL
g	NULL
a	NULL
t	NULL
G	NULL
t	NULL
g	NULL
T	NULL
GG	NULL
A	NULL
A	NULL
A	NULL
G	NULL
T	NULL
c	NULL
Coo	NULL
ag	NULL
t	NULL
a	NULL
g	NULL
|__	NULL
(	NULL
ars	NULL
100	NULL
)	NULL
|	NULL
|	NULL
___	NULL
(	NULL
nEkB	NULL
8/10	NULL
)	NULL
_|	NULL
|___	NULL
ii	NULL
(	NULL
NF-kB	NULL
)	NULL
__|	NULL
NF-KB	NULL
(	NULL
h-IL2	NULL
)	NULL
g	NULL
g	NULL
a	NULL
T	NULL
G	NULL
t	NULL
a	NULL
g	NULL
g	NULL
t	NULL
G	NULL
A	NULL
A	NULL
A	NULL
t	NULL
c	NULL
c	NULL
C	NULL
t	NULL
ct	NULL
t	NULL
t	NULL
g	NULL
|_	NULL
__mwrks	NULL
s10	NULL
)	NULL
_|	NULL
NFAT	NULL
(	NULL
h-IL2	NULL
)	NULL
a	NULL
g	NULL
a	NULL
a	NULL
a	NULL
G	NULL
g	NULL
a	NULL
G	NULL
G	NULL
A	NULL
A	NULL
A	NULL
a	NULL
a	NULL
c	NULL
t	NULL
g	NULL
t	NULL
t	NULL
t	NULL
C	NULL
a	NULL
t	NULL
A	NULL
c	NULL
a	NULL
g	NULL
a	NULL
a	NULL
g	NULL
g	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
sequence	NULL
to	NULL
various	NULL
enhancer	NULL
domains	NULL
.	NULL

The	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
region	NULL
defined	NULL
by	NULL
DNase	NULL
I	NULL
protection	NULL
,	NULL
from	NULL
-349	NULL
to	NULL
-825	NULL
,	NULL
is	NULL
indicated	NULL
,	NULL
as	NULL
is	NULL
a	NULL
short	NULL
inverted	NULL
repeat	NULL
sequence	NULL
.	NULL

The	NULL
sequences	NULL
shown	NULL
here	NULL
correspond	NULL
to	NULL
the	NULL
oligonucleotides	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
used	NULL
in	NULL
the	NULL
mobility	NULL
shift	NULL
experiments	NULL
(	NULL
Figs	NULL
.	NULL

8-11	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
motifs	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
in	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
is	NULL
on	NULL
the	NULL
opposite	NULL
strand	NULL
(	NULL
dashed	NULL
underline	NULL
)	NULL
.	NULL

Numbers	NULL
in	NULL
parentheses	NULL
indicate	NULL
the	NULL
number	NULL
of	NULL
matches	NULL
to	NULL
the	NULL
reported	NULL
consensus	NULL
binding	NULL
sequence	NULL
(	NULL
11	NULL
)	NULL
;	NULL
AP2	NULL
CCC	NULL
(	NULL
A/C	NULL
)	NULL
N	NULL
(	NULL
G/C	NULL
)	NULL
(	NULL
G/	NULL
C	NULL
)	NULL
(	NULL
G/C	NULL
)	NULL
;	NULL
AP3	NULL
,	NULL
TGTGG	NULL
{	NULL
A/T	NULL
)	NULL
(	NULL
A/T	NULL
)	NULL
(	NULL
A/T	NULL
)	NULL
GT	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
GGGA	NULL
(	NULL
A/C	NULL
)	NULL
TN	NULL
(	NULL
T/C	NULL
)	NULL
CC	NULL
.	NULL

Mismatches	NULL
of	NULL
the	NULL
SV40	NULL
,	NULL
NF-xB	NULL
,	NULL
and	NULL
NFAT	NULL
motifs	NULL
with	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
lowercase	NULL
.	NULL

The	NULL
GGAAA	NULL
motif	NULL
characteristic	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
of	NULL
proteins	NULL
is	NULL
underlined	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
T	NULL
Cell-specific	NULL
Enhancer	NULL
in	NULL
MMTV	NULL
env	NULL
Gene	NULL
8949	NULL
NEK-	NULL
+/+	NULL
=I	NULL
Competing	NULL
Oligo	NULL
I	NULL
--	NULL
|	NULL
AP-3/83v40	NULL
hIL-2	NULL
NF-KB	NULL
NS	NULL
I	NULL
Amoun1	NULL
(	NULL
x	NULL
)	NULL
~~98	NULL
%	NULL
§°88	NULL
§§85§	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Competition	NULL
by	NULL
AP3	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequences	NULL
for	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
-binding	NULL
proteins	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
labeled	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
probe	NULL
and	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
,	NULL
either	NULL
an	NULL
SV40-derived	NULL
AP3	NULL
site	NULL
(	NULL
sequences	NULL
SAP3	NULL
and	NULL
AAP3	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
or	NULL
hIL2-derived	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
809	NULL
and	NULL
A10	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
no	NULL
competitor	NULL
;	NULL
lanes	NULL
3-6	NULL
,	NULL
AP3/SV40	NULL
competitor	NULL
;	NULL
lanes	NULL
7-11	NULL
,	NULL
hIL2	NULL
NF-	NULL
«	NULL
B	NULL
competitor	NULL
;	NULL
lanes	NULL
12-14	NULL
,	NULL
nonspecific	NULL
oligonucleotide	NULL
competitor	NULL
,	NULL
corresponding	NULL
to	NULL
positions	NULL
-125	NULL
to	NULL
-96	NULL
of	NULL
META	NULL
(	NULL
sequences	NULL
S20	NULL
plus	NULL
A20	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Other	NULL
symbols	NULL
and	NULL
conditions	NULL
are	NULL
as	NULL
in	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
.	NULL

The	NULL
region	NULL
of	NULL
free	NULL
probe	NULL
is	NULL
not	NULL
shown	NULL
in	NULL
this	NULL
autoradiogram	NULL
.	NULL

nel	NULL
-	NULL
+	NULL
csa	NULL
+	NULL
Call	NULL
|	NULL
Competing	NULL
Oligo	NULL
Seif	NULL
metane	NULL
)	NULL
|	NULL
nreneks	NULL
[	NULL
ns	NULL
_I	NULL
Amount	NULL
(	NULL
x	NULL
)	NULL
2	NULL
g	NULL
8	NULL
g	NULL
8	NULL
933§§	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
8	NULL
10	NULL
1112	NULL
18	NULL
14	NULL
15	NULL
18	NULL
17	NULL
18	NULL
i9	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Binding	NULL
of	NULL
induced	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
AP3	NULL
probe	NULL
.	NULL

Labeled	NULL
AP3	NULL
probe	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
was	NULL
used	NULL
with	NULL
unlabeled	NULL
oligonucleotide	NULL
competitors	NULL
.	NULL

Lanes	NULL
1-3	NULL
,	NULL
no	NULL
competitor	NULL
;	NULL
lames	NULL
4-7	NULL
,	NULL
unlabeled	NULL
AP3/SV40	NULL
oligonucleotide	NULL
(	NULL
self	NULL
)	NULL
;	NULL
Zanes	NULL
8-12	NULL
,	NULL
unlabeled	NULL
META	NULL
D+	NULL
)	NULL
oligonucleotide	NULL
;	NULL
lanes	NULL
13-18	NULL
,	NULL
unlabeled	NULL
hIL2	NULL
NF-kB	NULL
oligonucleotide	NULL
;	NULL
lanes	NULL
18	NULL
and	NULL
19	NULL
,	NULL
a	NULL
nonspecific	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
sequence	NULL
from	NULL
-125	NULL
to	NULL
-96	NULL
of	NULL
META	NULL
(	NULL
sequences	NULL
S20	NULL
plus	NULL
A20	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Other	NULL
symbols	NULL
and	NULL
conditions	NULL
are	NULL
as	NULL
in	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
.	NULL

Free	NULL
probe	NULL
not	NULL
shown	NULL
.	NULL

negatively	NULL
regulate	NULL
expression	NULL
of	NULL
inducible	NULL
genes	NULL
(	NULL
36	NULL
)	NULL
,	NULL
including	NULL
c-fos	NULL
(	NULL
37	NULL
)	NULL
and	NULL
human	NULL
B-interferon	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
dyad	NULL
symmetry	NULL
element	NULL
encompasses	NULL
an	NULL
AP2	NULL
motif	NULL
(	NULL
7/8	NULL
)	NULL
,	NULL
but	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
that	NULL
it	NULL
bound	NULL
an	NULL
inducible	NULL
protein	NULL
.	NULL

Given	NULL
the	NULL
similarities	NULL
in	NULL
the	NULL
transcription	NULL
regulatory	NULL
properties	NULL
of	NULL
META	NULL
and	NULL
the	NULL
IL2	NULL
upstream	NULL
region	NULL
(	NULL
13	NULL
)	NULL
,	NULL
it	NULL
was	NULL
reasonable	NULL
to	NULL
suppose	NULL
that	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
element	NULL
might	NULL
be	NULL
responding	NULL
to	NULL
the	NULL
IL2-related	NULL
NFAT	NULL
binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
human	NULL
IL2	NULL
NFAT	NULL
probe	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
in	NULL
gel	NULL
shift	NULL
analysis	NULL
.	NULL

A	NULL
general	NULL
hypothesis	NULL
explaining	NULL
the	NULL
action	NULL
of	NULL
CsA	NULL
has	NULL
been	NULL
proposed	NULL
,	NULL
which	NULL
involves	NULL
a	NULL
complex	NULL
of	NULL
proteins	NULL
recognizing	NULL
NFAT	NULL
plus	NULL
one	NULL
of	NULL
several	NULL
ancillary	NULL
proteins	NULL
such	NULL
as	NULL
AP1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
or	NULL
Oct	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

The	NULL
lysolecithin	NULL
method	NULL
we	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
to	NULL
extract	NULL
nuclear	NULL
binding	NULL
proteins	NULL
utilizes	NULL
0.6	NULL
M	NULL
KCI	NULL
.	NULL

The	NULL
more	NULL
conventional	NULL
methods	NULL
depend	NULL
on	NULL
hypotonic	NULL
shock	NULL
and	NULL
ammonium	NULL
sulfate	NULL
precipitation	NULL
of	NULL
nuclear	NULL
proteins	NULL
(	NULL
13	NULL
,	NULL
22	NULL
)	NULL
.	NULL

NFAT	NULL
binding	NULL
is	NULL
diminished	NULL
if	NULL
the	NULL
salt	NULL
concentration	NULL
used	NULL
for	NULL
protein	NULL
preparation	NULL
or	NULL
for	NULL
binding	NULL
reactions	NULL
exceeds	NULL
0.3	NULL
M	NULL
KCI	NULL
(	NULL
41	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
probe	NULL
also	NULL
bound	NULL
inducible	NULL
nuclear	NULL
factors	NULL
obtained	NULL
by	NULL
conventional	NULL
methods	NULL
of	NULL
extraction	NULL
,	NULL
and	NULL
this	NULL
binding	NULL
was	NULL
also	NULL
not	NULL
competed	NULL
by	NULL
NFAT	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
human	NULL
IL2	NULL
upstream	NULL
region	NULL
(	NULL
+45	NULL
to	NULL
-362	NULL
)	NULL
did	NULL
not	NULL
compete	NULL
for	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
,	NULL
nor	NULL
did	NULL
its	NULL
constituent	NULL
elements	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
NFAT	NULL
,	NULL
or	NULL
AP1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
only	NULL
strong	NULL
competition	NULL
for	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
was	NULL
by	NULL
the	NULL
SV40	NULL
AP3	NULL
element	NULL
(	NULL
33	NULL
)	NULL
,	NULL
which	NULL
encompasses	NULL
an	NULL
NF-KB	NULL
site	NULL
(	NULL
42	NULL
)	NULL
and	NULL
a	NULL
site	NULL
for	NULL
NP-TCII	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
constitutively	NULL
in	NULL
lymphocyte	NULL
nuclei	NULL
(	NULL
82	NULL
)	NULL
.	NULL

However	NULL
,	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
differs	NULL
from	NULL
each	NULL
of	NULL
these	NULL
factors	NULL
in	NULL
terms	NULL
of	NULL
its	NULL
T	NULL
helper	NULL
lymphocyte	NULL
specificity	NULL
,	NULL
its	NULL
dependence	NULL
on	NULL
activation	NULL
,	NULL
and	NULL
its	NULL
CsA	NULL
sensitivity	NULL
,	NULL
as	NULL
well	NULL
as	NULL
lack	NULL
of	NULL
competition	NULL
for	NULL
binding	NULL
.	NULL

8194	NULL
cells	NULL
(	NULL
a	NULL
B-cell	NULL
line	NULL
)	NULL
and	NULL
Hela	NULL
cells	NULL
(	NULL
fibroblast	NULL
)	NULL
are	NULL
known	NULL
to	NULL
produce	NULL
NF-kB	NULL
and	NULL
AP3	NULL
pro-teins	NULL
,	NULL
respectively	NULL
,	NULL
but	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
did	NULL
not	NULL
promote	NULL
transcriptional	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
either	NULL
uninduced	NULL
or	NULL
exposed	NULL
to	NULL
PMA	NULL
plus	NULL
A23187	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
short	NULL
,	NULL
its	NULL
properties	NULL
can	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
interaction	NULL
with	NULL
known	NULL
binding	NULL
factors	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
binding	NULL
factor	NULL
remains	NULL
uncertain	NULL
,	NULL
but	NULL
it	NULL
is	NULL
reasonable	NULL
to	NULL
speculate	NULL
that	NULL
an	NULL
NFATp/c	NULL
family	NULL
member	NULL
is	NULL
involved	NULL
(	NULL
43	NULL
)	NULL
,	NULL
perhaps	NULL
in	NULL
conjunction	NULL
with	NULL
other	NULL
components	NULL
that	NULL
differentiate	NULL
it	NULL
from	NULL
the	NULL
NF-AT	NULL
binding	NULL
factor	NULL
of	NULL
the	NULL
human	NULL
IL2	NULL
gene	NULL
.	NULL

The	NULL
mammary	NULL
cell-specific	NULL
expression	NULL
of	NULL
MMTV	NULL
in	NULL
mice	NULL
is	NULL
brought	NULL
about	NULL
by	NULL
the	NULL
net	NULL
actions	NULL
of	NULL
positively	NULL
acting	NULL
estrogen-dependent	NULL
elements	NULL
and	NULL
negative	NULL
elements	NULL
within	NULL
the	NULL
LTR	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
lymphomas	NULL
by	NULL
MMTV	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
the	NULL
loss	NULL
of	NULL
repressor	NULL
elements	NULL
in	NULL
the	NULL
control	NULL
regions	NULL
of	NULL
the	NULL
LTR	NULL
due	NULL
to	NULL
deletions	NULL
and/or	NULL
rearrangements	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
repressor	NULL
elements	NULL
between	NULL
-430	NULL
and	NULL
-360	NULL
in	NULL
the	NULL
LTR	NULL
promoted	NULL
transcription	NULL
of	NULL
this	NULL
viral	NULL
strain	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
44	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
concerted	NULL
action	NULL
of	NULL
the	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
enhancer	NULL
with	NULL
known	NULL
transcriptional	NULL
regulatory	NULL
sites	NULL
in	NULL
the	NULL
LTR	NULL
contributes	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
lymphomas	NULL
.	NULL

Enhancers	NULL
of	NULL
lymphotropic	NULL
papova	NULL
virus	NULL
,	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
,	NULL
and	NULL
T	NULL
lymphomagenic	NULL
virus	NULL
SL3-3	NULL
also	NULL
exhibit	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
homology	NULL
to	NULL
the	NULL
AP3	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
SV40	NULL
enhancer	NULL
(	NULL
45-47	NULL
)	NULL
.	NULL

These	NULL
enhancers	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
hematopoietic	NULL
malignancies	NULL
(	NULL
47	NULL
)	NULL
,	NULL
making	NULL
META	NULL
(	NULL
D+	NULL
)	NULL
a	NULL
candidate	NULL
enhancer	NULL
for	NULL
the	NULL
observed	NULL
MMTV-induced	NULL
T	NULL
cell	NULL
lymphomas	NULL
.	NULL

A	NULL
tantalizing	NULL
feature	NULL
of	NULL
META	NULL
is	NULL
that	NULL
it	NULL
regulates	NULL
the	NULL
expression	NULL
,	NULL
at	NULL
least	NULL
in	NULL
certain	NULL
T	NULL
lymphoma	NULL
cell	NULL
lines	NULL
,	NULL
of	NULL
the	NULL
LTR	NULL
transcript	NULL
,	NULL
which	NULL
normally	NULL
encodes	NULL
the	NULL
minor	NULL
histocompatibility	NULL
antigens	NULL
of	NULL
the	NULL
Mls	NULL
family	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

META	NULL
,	NULL
given	NULL
its	NULL
lymphoid-specific	NULL
induction	NULL
,	NULL
makes	NULL
an	NULL
attractive	NULL
candidate	NULL
for	NULL
the	NULL
regulator	NULL
of	NULL
Mls	NULL
antigen	NULL
expression	NULL
,	NULL
except	NULL
for	NULL
one	NULL
thing	NULL
;	NULL
so	NULL
far	NULL
,	NULL
we	NULL
have	NULL
seen	NULL
expression	NULL
only	NULL
in	NULL
T	NULL
lymphocytes	NULL
which	NULL
,	NULL
although	NULL
implicated	NULL
as	NULL
Mls	NULL
presenting	NULL
cells	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
tolerance	NULL
(	NULL
48	NULL
)	NULL
,	NULL
are	NULL
not	NULL
conventional	NULL
antigen-presenting	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
not	NULL
observed	NULL
META	NULL
activity	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
but	NULL
this	NULL
may	NULL
be	NULL
because	NULL
we	NULL
have	NULL
not	NULL
yet	NULL
looked	NULL
at	NULL
the	NULL
correct	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
proper	NULL
way	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
C.	NULL
L.	NULL
Miller	NULL
for	NULL
discussions	NULL
and	NULL
Cliff	NULL
Gibbs	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Peters	NULL
,	NULL
G.	NULL
,	NULL
Lee	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
and	NULL
Dickson	NULL
,	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
820	NULL
,	NULL
628-631	NULL
2	NULL
.	NULL

Ball	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Diggelmann	NULL
,	NULL
H.	NULL
,	NULL
Dekaban	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Grossi	NULL
,	NULL
G.	NULL
F.	NULL
,	NULL
Semmler	NULL
,	NULL
R.	NULL
,	NULL
Waight	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Fletcher	NULL
,	NULL
R.	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
2985-2993	NULL
3	NULL
.	NULL

Yanagawa	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
Kakimi	NULL
,	NULL
K.	NULL
,	NULL
Tanaka	NULL
,	NULL
H.	NULL
,	NULL
Murakami	NULL
,	NULL
A.	NULL
,	NULL
Nakagawa	NULL
,	NULL
Y.	NULL
,	NULL
Kubo	NULL
,	NULL
Y.	NULL
,	NULL
Yamada	NULL
,	NULL
Y.	NULL
,	NULL
Hiai	NULL
,	NULL
H.	NULL
,	NULL
Kuribayashi	NULL
,	NULL
K.	NULL
,	NULL
Masuda	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ishimoto	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

67	NULL
,	NULL
112-118	NULL
.	NULL

Beutner	NULL
,	NULL
U.	NULL
,	NULL
Frankel	NULL
,	NULL
W.	NULL
N.	NULL
,	NULL
Cote	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Coffin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Huber	NULL
,	NULL
B.	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
5482-5436	NULL
.	NULL

Choi	NULL
,	NULL
Y.	NULL
,	NULL
Kappler	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Marrack	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
850	NULL
,	NULL
203-207	NULL
.	NULL

Esser	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Parham	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
859	NULL
,	NULL
19-20	NULL
.	NULL

Chandler	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
Maler	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
83	NULL
,	NULL
489-499	NULL
Elliott	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Pohajdak	NULL
,	NULL
B.	NULL
,	NULL
Talbot	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Shaw	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Paetkau	NULL
,	NULL
V.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
1373-1380	NULL
.	NULL

Miller	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Garner	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Paetkau	NULL
,	NULL
V.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3262-3272	NULL
.	NULL

Moore	NULL
,	NULL
R.	NULL
,	NULL
Dixon	NULL
,	NULL
M.	NULL
,	NULL
Smith	NULL
,	NULL
R.	NULL
,	NULL
Peters	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Dickson	NULL
,	NULL
C.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

61	NULL
,	NULL
480-490	NULL
11	NULL
.	NULL

Faisst	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Meyer	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
3-26	NULL
12	NULL
.	NULL

Mink	NULL
,	NULL
S.	NULL
,	NULL
Hartig	NULL
,	NULL
E.	NULL
,	NULL
Jennewein	NULL
,	NULL
P.	NULL
,	NULL
Doppler	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Cato	NULL
,	NULL
A.	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
p~goco	NULL
op	NULL
0	NULL
©	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
8950	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4906-4918	NULL
Serfling	NULL
,	NULL
E.	NULL
,	NULL
Barthelmas	NULL
,	NULL
R.	NULL
,	NULL
Pfeuffer	NULL
,	NULL
I.	NULL
,	NULL
Schenk	NULL
,	NULL
B.	NULL
,	NULL
Zarius	NULL
,	NULL
S.	NULL
,	NULL
Swoboda	NULL
,	NULL
R.	NULL
,	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
465-473	NULL
Kwon	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

52	NULL
,	NULL
1000-1004	NULL
Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
421-452	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Clipstone	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

68	NULL
,	NULL
1045-1083	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Bush	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Replogle	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Belagaje	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1715-1724	NULL
Hentsch	NULL
,	NULL
B.	NULL
,	NULL
Mouzaki	NULL
,	NULL
A.	NULL
,	NULL
Pfeuffer	NULL
,	NULL
I.	NULL
,	NULL
Rungger	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
2657-2665	NULL
Brunvand	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Krumm	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
4824-4829	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Higgins	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Lacy	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
1617-1620	NULL
Hooton	NULL
,	NULL
J.	NULL
W.	NULL
L.	NULL
,	NULL
Gibbs	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Paetkau	NULL
,	NULL
V.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

195	NULL
,	NULL
2464-2473	NULL
Zerivitz	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Akusjarvi	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Gene	NULL
Anal	NULL
.	NULL

Tech	NULL
.	NULL

6	NULL
,	NULL
101-109	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
pp	NULL
.	NULL

7.179-7.83	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Ohashi	NULL
,	NULL
T.	NULL
,	NULL
Yamanishi	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
401-407	NULL
Davidson	NULL
,	NULL
I.	NULL
,	NULL
Fromental	NULL
,	NULL
C.	NULL
,	NULL
Augereau	NULL
,	NULL
P.	NULL
,	NULL
Wildeman	NULL
,	NULL
A.	NULL
,	NULL
Zenke	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
828	NULL
,	NULL
544-551	NULL
Lobe	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Shaw	NULL
,	NULL
J.	NULL
,	NULL
Fregeau	NULL
,	NULL
C.	NULL
,	NULL
Duggan	NULL
,	NULL
B.	NULL
,	NULL
Meier	NULL
,	NULL
M.	NULL
,	NULL
Brewer	NULL
,	NULL
A.	NULL
,	NULL
Upton	NULL
,	NULL
C.	NULL
,	NULL
McFadden	NULL
,	NULL
G.	NULL
,	NULL
Patient	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Paetkau	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Bleackley	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
5765-5779	NULL
Morgan	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Evans	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Lee	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Pulleyblank	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1979	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

7	NULL
,	NULL
571-594	NULL
Brasier	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Tate	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Habener	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
BioTechniques	NULL
7	NULL
,	NULL
1116-1122	NULL
29	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

T	NULL
Cell-specific	NULL
Enhancer	NULL
in	NULL
MMTV	NULL
env	NULL
Gene	NULL
.	NULL

McGuire	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Curtiss	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
Larson	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

67	NULL
,	NULL
1590-1599	NULL
Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
10028-10032	NULL
Briegel	NULL
,	NULL
K.	NULL
,	NULL
Hentsch	NULL
,	NULL
B.	NULL
,	NULL
Pfeuffer	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
5929-5936	NULL
Lattion	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Espel	NULL
,	NULL
E.	NULL
,	NULL
Reichenbach	NULL
,	NULL
P.	NULL
,	NULL
Fromental	NULL
,	NULL
C.	NULL
,	NULL
Bucher	NULL
,	NULL
P.	NULL
,	NULL
Israel	NULL
,	NULL
A.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
5217-5227	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
1455-1460	NULL
Espel	NULL
,	NULL
E.	NULL
,	NULL
Fromental	NULL
,	NULL
C.	NULL
,	NULL
Reichenbach	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
929-937	NULL
Novak	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Rothenberg	NULL
,	NULL
E.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
6325-6334	NULL
Clark	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
and	NULL
Docherty	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

296	NULL
,	NULL
521-541	NULL
Kénig	NULL
,	NULL
H.	NULL
,	NULL
Ponta	NULL
,	NULL
H.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
U.	NULL
,	NULL
Biischer	NULL
,	NULL
M.	NULL
,	NULL
Schinthal	NULL
,	NULL
A.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
2559-2566	NULL
Goodbourn	NULL
,	NULL
S.	NULL
,	NULL
Burstein	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
45	NULL
,	NULL
601-610	NULL
Mccaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
750-754	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
274-281	NULL
.	NULL

Corthesy	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Kao	NULL
,	NULL
P.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
20682-20690	NULL
.	NULL

Macchi	NULL
,	NULL
M.	NULL
,	NULL
Bornert	NULL
,	NULL
J.-M.	NULL
,	NULL
Davidson	NULL
,	NULL
I.	NULL
,	NULL
Kanno	NULL
,	NULL
M.	NULL
,	NULL
Rosales	NULL
,	NULL
R.	NULL
,	NULL
Vigneron	NULL
,	NULL
M.	NULL
,	NULL
Xiao	NULL
,	NULL
J.-H.	NULL
,	NULL
Fromental	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
4215-4227	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
795-798	NULL
.	NULL

Giffin	NULL
,	NULL
W.	NULL
,	NULL
Torrance	NULL
,	NULL
H.	NULL
,	NULL
Saffran	NULL
,	NULL
H.	NULL
,	NULL
Macleod	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
and	NULL
Hache	NULL
,	NULL
R.	NULL
J.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
1449-1459	NULL
.	NULL

Wang	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
and	NULL
Speck	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
89-102	NULL
.	NULL

Boral	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Okengquist	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Lenz	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

68	NULL
,	NULL
76-84	NULL
.	NULL

Mosthaf	NULL
,	NULL
L.	NULL
,	NULL
Pawlita	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
815	NULL
,	NULL
597-600	NULL
.	NULL

Webb	NULL
,	NULL
S.	NULL
,	NULL
Morris	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Sprent	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
1249-1256	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Interactions	NULL
of	NULL
a	NULL
Transcriptional	NULL
Activator	NULL
in	NULL
the	NULL
env	NULL
Gene	NULL
of	NULL
the	NULL
Mouse	NULL
Mammary	NULL
Tumor	NULL
Virus	NULL
with	NULL
Activation-dependent	NULL
,	NULL
T	NULL
Cell-specific	NULL
Transacting	NULL
Factors	NULL
Damaraju	NULL
Sambasivarao	NULL
and	NULL
Verner	NULL
Paetkau	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:8942-8950.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.15.8942	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/15/8942	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
47	NULL
references	NULL
,	NULL
21	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
5/8942	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

